| 1 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services.
|
| 2 |
Carmustine-induced toxicity, DNA crosslinking and O6-methylguanine-DNA methyltransferase activity in two human lung cancer cell lines. Eur J Cancer. 1991;27(12):1658-62.
|
| 3 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
|
| 4 |
Floxuridine FDA Label
|
| 5 |
ClinicalTrials.gov (NCT01031966) A Pilot Study to Evaluate ZADAXIN's (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine. U.S. National Institutes of Health.
|
| 6 |
ClinicalTrials.gov (NCT01749306) A Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not Healing. U.S. National Institutes ofHealth.
|
| 7 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5671).
|
| 8 |
ClinicalTrials.gov (NCT02017678) Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin. U.S. National Institutes of Health.
|
| 9 |
ClinicalTrials.gov (NCT04194775) A Multi-Center, Double-Blind, Randomized, Phase III Study to Investigate the Efficacy and Safety of Nofazinlimab (CS1003) in Combination With Lenvatinib Compared to Placebo in Combination With Lenvatinib as First-Line Therapy in Subjects With Advanced Hepatocellular Carcinoma (HCC). U.S.National Institutes of Health.
|
| 10 |
ClinicalTrials.gov (NCT00034333) Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer. U.S. National Institutes of Health.
|
| 11 |
PRODUCTS: BrachySil. Psivida corp
|
| 12 |
ClinicalTrials.gov (NCT01232452) A Study in Non-Small Cell Lung Cancer. U.S. National Institutes of Health.
|
| 13 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021589)
|
| 14 |
ClinicalTrials.gov (NCT00421213) Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers. U.S. National Institutes of Health.
|
| 15 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026037)
|
| 16 |
ClinicalTrials.gov (NCT00730158) A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer. U.S. National Institutes of Health.
|
| 17 |
ClinicalTrials.gov (NCT01307891) Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer. U.S. National Institutes of Health.
|
| 18 |
ClinicalTrials.gov (NCT00819650) A Trial of Licartin for Preventing Tumor Recurrence After Liver Resection. U.S. National Institutes of Health.
|
| 19 |
ClinicalTrials.gov (NCT01882946) Safety and Efficacy Study of DCVax-Direct in Solid Tumors. U.S. National Institutes of Health.
|
| 20 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 21 |
Clinical pipeline report, company report or official report of Metabasis Therapeutics (2006).
|
| 22 |
ClinicalTrials.gov (NCT00149396) Safety and Efficacy of a Genetically Engineered Herpes Simplex Virus NV1020 to Treat Colorectal Cancer Metastatic to Liver. U.S. National Institutes of Health.
|
| 23 |
ClinicalTrials.gov (NCT02293850) Phase I/II Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma. U.S. National Institutes of Health.
|
| 24 |
ClinicalTrials.gov (NCT03132792) A Phase I Open Label Clinical Trial Evaluating the Safety and Anti-Tumor Activity of Autologous T Cells Expressing Enhanced TCRs Specific for Alpha Fetoprotein (AFP????T) in HLA-A2 Positive Subjects With Advanced Hepatocellular Carcinoma (HCC) or Other AFP Expressing Tumor Types. U.S.National Institutes of Health.
|
| 25 |
Clinical pipeline report, company report or official report of Alnylam Pharmaceuticals, Inc (2011).
|
| 26 |
ClinicalTrials.gov (NCT02541370) Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133
|
| 27 |
ClinicalTrials.gov (NCT03349255) Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma
|
| 28 |
ClinicalTrials.gov (NCT00327652) Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases. U.S. National Institutes of Health.
|
| 29 |
ClinicalTrials.gov (NCT03965546) Clinical Study of ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Advanced Liver Cancer. U.S.National Institutes of Health.
|
| 30 |
ClinicalTrials.gov (NCT01829971) A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection. U.S. National Institutes of Health.
|
| 31 |
Clinical pipeline report, company report or official report of Progen.
|
| 32 |
ClinicalTrials.gov (NCT02191761) Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer. U.S. National Institutes of Health.
|
| 33 |
ClinicalTrials.gov (NCT04374877) Study of SRF388 in Patients With Advanced Solid Tumors. U.S. National Institutes of Health.
|
| 34 |
ClinicalTrials.gov (NCT02729493) Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer
|
| 35 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003116)
|
| 36 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008092)
|
| 37 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015394)
|
| 38 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009854)
|
| 39 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018427)
|
| 40 |
Circadian rhythm as a therapeutic target. Nat Rev Drug Discov. 2021 Apr;20(4):287-307.
|
| 41 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020214)
|
| 42 |
Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. J Nutr. 2007 Nov;137(11):2366-70.
|
| 43 |
The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
|
| 44 |
Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survival.Scand J Gastroenterol. 2018 Oct-Nov;53(10-11):1368-1375. doi: 10.1080/00365521.2018.1517277. Epub 2018 Nov 5.
|
| 45 |
Constitutive Activation of the Human Aryl Hydrocarbon Receptor in Mice Promotes Hepatocarcinogenesis Independent of Its Coactivator Gadd45b.Toxicol Sci. 2019 Feb 1;167(2):581-592. doi: 10.1093/toxsci/kfy263.
|
| 46 |
Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.IUBMB Life. 2020 Feb;72(2):285-295. doi: 10.1002/iub.2166. Epub 2019 Oct 3.
|
| 47 |
Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma.Cancer Res. 2018 Aug 15;78(16):4731-4744. doi: 10.1158/0008-5472.CAN-17-2459. Epub 2018 Jun 18.
|
| 48 |
Biocompatible co-loading vehicles for delivering both nanoplatin cores and siRNA to treat hepatocellular carcinoma.Int J Pharm. 2019 Dec 15;572:118769. doi: 10.1016/j.ijpharm.2019.118769. Epub 2019 Oct 26.
|
| 49 |
MicroRNA-26b inhibits the tumor growth of human liver cancer through the PI3K/Akt and NF-B/MMP-9/VEGF pathways.Oncol Rep. 2018 May;39(5):2288-2296. doi: 10.3892/or.2018.6289. Epub 2018 Mar 1.
|
| 50 |
Cytisine induces endoplasmic reticulum stress caused by calcium overload in HepG2 cells.Oncol Rep. 2018 Mar;39(3):1475-1484. doi: 10.3892/or.2018.6200. Epub 2018 Jan 8.
|
| 51 |
Reduced CD160 Expression Contributes to Impaired NK-cell Function and Poor Clinical Outcomes in Patients with HCC.Cancer Res. 2018 Dec 1;78(23):6581-6593. doi: 10.1158/0008-5472.CAN-18-1049. Epub 2018 Sep 19.
|
| 52 |
Levels of HBx, VEGF, and CEACAM1 in HBV-related hepatocellular carcinoma and their correlation with cancer prognosis.Eur Rev Med Pharmacol Sci. 2017 Oct;21(17):3827-3833.
|
| 53 |
In vivo inhibitory activity of andrographolide derivative ADN-9 against liver cancer and its mechanisms involved in inhibition of tumor angiogenesis.Toxicol Appl Pharmacol. 2017 Jul 15;327:1-12. doi: 10.1016/j.taap.2017.04.022. Epub 2017 Apr 22.
|
| 54 |
Prosurvival function of the cellular apoptosis susceptibility/importin-1 transport cycle is repressed by p53 in liver cancer.Hepatology. 2014 Sep;60(3):884-95. doi: 10.1002/hep.27207. Epub 2014 Jul 17.
|
| 55 |
Bioinformatic analysis reveals CYP2C9 as a potential prognostic marker for HCC and liver cancer cell lines suitable for its mechanism study.Cell Mol Biol (Noisy-le-grand). 2018 May 30;64(7):70-74.
|
| 56 |
Increased liver carcinogenesis and enrichment of stem cell properties in livers of Dickkopf 2 (Dkk2) deleted mice.Oncotarget. 2016 May 17;7(20):28903-13. doi: 10.18632/oncotarget.3293.
|
| 57 |
Targeting DTL induces cell cycle arrest and senescence and suppresses cell growth and colony formation through TPX2 inhibition in human hepatocellular carcinoma cells.Onco Targets Ther. 2018 Mar 21;11:1601-1616. doi: 10.2147/OTT.S147453. eCollection 2018.
|
| 58 |
Karyopherin 2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.Cell Commun Signal. 2019 Nov 29;17(1):159. doi: 10.1186/s12964-019-0456-x.
|
| 59 |
Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.J Hepatol. 2017 Oct;67(4):758-769. doi: 10.1016/j.jhep.2017.05.015. Epub 2017 May 19.
|
| 60 |
TGF-1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p.Oncogene. 2020 Feb;39(8):1807-1820. doi: 10.1038/s41388-019-1107-9. Epub 2019 Nov 18.
|
| 61 |
Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population.Oncotarget. 2016 Nov 8;7(45):73754-73768. doi: 10.18632/oncotarget.12062.
|
| 62 |
High glucose stimulates proliferative capacity of liver cancer cells possibly via O-GlcNAcylation-dependent transcriptional regulation of GJC1.J Cell Physiol. 2018 Jan;234(1):606-618. doi: 10.1002/jcp.26803. Epub 2018 Aug 5.
|
| 63 |
Identification of recurrent fusion genes across multiple cancer types.Sci Rep. 2019 Jan 31;9(1):1074. doi: 10.1038/s41598-019-38550-6.
|
| 64 |
Participation of liver stem cells in cholangiocarcinogenesis after aflatoxin B(1) exposure of glutathione S-transferase A3 knockout mice.Tumour Biol. 2018 May;40(5):1010428318777344. doi: 10.1177/1010428318777344.
|
| 65 |
High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models.Lab Invest. 2018 Jan;98(1):95-105. doi: 10.1038/labinvest.2017.107. Epub 2017 Oct 16.
|
| 66 |
HOXA7 plays a critical role in metastasis of liver cancer associated with activation of Snail.Mol Cancer. 2016 Sep 6;15(1):57. doi: 10.1186/s12943-016-0540-4.
|
| 67 |
CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78).FASEB J. 2018 Jul;32(7):3878-3891. doi: 10.1096/fj.201700941RR. Epub 2018 Feb 20.
|
| 68 |
Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.FASEB J. 2016 Jan;30(1):262-75. doi: 10.1096/fj.15-277749. Epub 2015 Sep 1.
|
| 69 |
TC Mps1 12, a novel Mps1 inhibitor, suppresses the growth of hepatocellular carcinoma cells via the accumulation of chromosomal instability.Br J Pharmacol. 2017 Jun;174(12):1810-1825. doi: 10.1111/bph.13782. Epub 2017 Apr 22.
|
| 70 |
ISG15 inhibits IFN--resistant liver cancer cell growth.Biomed Res Int. 2013;2013:570909. doi: 10.1155/2013/570909. Epub 2013 Aug 20.
|
| 71 |
MBD3 inhibits formation of liver cancer stem cells.Oncotarget. 2017 Jan 24;8(4):6067-6078. doi: 10.18632/oncotarget.13496.
|
| 72 |
HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372.Oncotarget. 2017 Jul 25;8(30):49093-49109. doi: 10.18632/oncotarget.17095.
|
| 73 |
Pseudopod-associated protein KIF20B promotes Gli1-induced epithelial-mesenchymal transition modulated by pseudopodial actin dynamic in human colorectal cancer.Mol Carcinog. 2018 Jul;57(7):911-925. doi: 10.1002/mc.22812. Epub 2018 Apr 10.
|
| 74 |
KISS1/KISS1R in Cancer: Friend or Foe?.Front Endocrinol (Lausanne). 2018 Aug 3;9:437. doi: 10.3389/fendo.2018.00437. eCollection 2018.
|
| 75 |
The Paradoxical Role of NKG2D in Cancer Immunity.Front Immunol. 2018 Aug 13;9:1808. doi: 10.3389/fimmu.2018.01808. eCollection 2018.
|
| 76 |
Identifying Key Genes of Liver Cancer by Networking of Multiple Data Sets.IEEE/ACM Trans Comput Biol Bioinform. 2018 Oct 5. doi: 10.1109/TCBB.2018.2874238. Online ahead of print.
|
| 77 |
Mitogen-activated protein kinase-activated protein kinase 2 mediates resistance to hydrogen peroxide-induced oxidative stress in human hepatobiliary cancer cells.Free Radic Biol Med. 2015 Dec;89:34-46. doi: 10.1016/j.freeradbiomed.2015.07.011. Epub 2015 Jul 11.
|
| 78 |
Biological Response Modifier in Cancer Immunotherapy.Adv Exp Med Biol. 2016;909:69-138. doi: 10.1007/978-94-017-7555-7_2.
|
| 79 |
Taurolidine promotes cell apoptosis by enhancing GRIM?9 expression in liver cancer.Oncol Rep. 2018 Dec;40(6):3743-3751. doi: 10.3892/or.2018.6711. Epub 2018 Sep 18.
|
| 80 |
NEDD4 promotes cell growth and motility in hepatocellular carcinoma.Cell Cycle. 2018;17(6):728-738. doi: 10.1080/15384101.2018.1440879. Epub 2018 Apr 10.
|
| 81 |
Asymmetric localization of DLC1 defines avian trunk neural crest polarity for directional delamination and migration.Nat Commun. 2017 Oct 30;8(1):1185. doi: 10.1038/s41467-017-01107-0.
|
| 82 |
Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.Int J Cancer. 2017 Apr 1;140(7):1581-1596. doi: 10.1002/ijc.30559. Epub 2017 Jan 19.
|
| 83 |
TO901317 inhibits the development of hepatocellular carcinoma by LXR/Glut1 decreasing glycometabolism.Am J Physiol Gastrointest Liver Physiol. 2019 May 1;316(5):G598-G607. doi: 10.1152/ajpgi.00061.2018. Epub 2019 Feb 28.
|
| 84 |
NUAK2 is a critical YAP target in liver cancer.Nat Commun. 2018 Nov 16;9(1):4834. doi: 10.1038/s41467-018-07394-5.
|
| 85 |
PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitro hepatocellular carcinoma models.BMC Cancer. 2014 Aug 20;14:603. doi: 10.1186/1471-2407-14-603.
|
| 86 |
K-Ras-PI3K regulates H3K56ac through PCAF to elevate the occurrence and growth of liver cancer.J Cell Physiol. 2020 Apr;235(4):3905-3915. doi: 10.1002/jcp.29284. Epub 2019 Oct 22.
|
| 87 |
Therapeutic Effect of Sorafenib-Loaded TPGS-b-PCL Nanoparticles on Liver Cancer.J Biomed Nanotechnol. 2018 Feb 1;14(2):396-403. doi: 10.1166/jbn.2018.2529.
|
| 88 |
Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting -catenin by activating PKM2 and inactivating PTEN.Cell Death Dis. 2018 Feb 15;9(3):253. doi: 10.1038/s41419-018-0305-7.
|
| 89 |
Inhibiting TrxR suppresses liver cancer by inducing apoptosis and eliciting potent antitumor immunity.Oncol Rep. 2018 Dec;40(6):3447-3457. doi: 10.3892/or.2018.6740. Epub 2018 Sep 27.
|
| 90 |
Increased expression of GATA zinc finger domain containing 1 through gene amplification promotes liver cancer by directly inducing phosphatase of regenerating liver 3.Hepatology. 2018 Jun;67(6):2302-2319. doi: 10.1002/hep.29750. Epub 2018 Mar 23.
|
| 91 |
Rab22a enhances CD147 recycling and is required for lung cancer cell migration and invasion.Exp Cell Res. 2017 Aug 1;357(1):9-16. doi: 10.1016/j.yexcr.2017.04.020. Epub 2017 Apr 19.
|
| 92 |
A CD13-targeting peptide integrated protein inhibits human liver cancer growth by killing cancer stem cells and suppressing angiogenesis.Mol Carcinog. 2017 May;56(5):1395-1404. doi: 10.1002/mc.22600. Epub 2017 Jan 4.
|
| 93 |
SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer.EMBO Rep. 2018 May;19(5):e45124. doi: 10.15252/embr.201745124. Epub 2018 Feb 28.
|
| 94 |
The Loss-of-Function S267F Variant in HBV Receptor NTCP Reduces Human Risk for HBV Infection and Disease Progression.J Infect Dis. 2018 Sep 22;218(9):1404-1410. doi: 10.1093/infdis/jiy355.
|
| 95 |
Flipping a citrate switch on liver cancer cells.J Biol Chem. 2017 Aug 18;292(33):13902-13903. doi: 10.1074/jbc.H117.783860.
|
| 96 |
Basigin-mediated redistribution of CD98 promotes cell spreading and tumorigenicity in hepatocellular carcinoma.J Exp Clin Cancer Res. 2015 Oct 6;34:110. doi: 10.1186/s13046-015-0226-6.
|
| 97 |
Deletion of sphingosine kinase 1 inhibits liver tumorigenesis in diethylnitrosamine-treated mice.Oncotarget. 2018 Feb 26;9(21):15635-15649. doi: 10.18632/oncotarget.24583. eCollection 2018 Mar 20.
|
| 98 |
MicroRNA-338-3p Suppresses Proliferation of Human Liver Cancer Cells by Targeting SphK2.Oncol Res. 2018 Sep 14;26(8):1183-1189. doi: 10.3727/096504018X15151495109394. Epub 2018 Jan 10.
|
| 99 |
Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer.Oncogene. 2018 Aug;37(32):4443-4454. doi: 10.1038/s41388-018-0291-3. Epub 2018 May 3.
|
| 100 |
Identification of copy number variation-driven genes for liver cancer via bioinformatics analysis.Oncol Rep. 2014 Nov;32(5):1845-52. doi: 10.3892/or.2014.3425. Epub 2014 Aug 20.
|
| 101 |
HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2.Sci Rep. 2016 Oct 26;6:36045. doi: 10.1038/srep36045.
|
| 102 |
Talin-1 correlates with reduced invasion and migration in human hepatocellular carcinoma cells.Asian Pac J Cancer Prev. 2014;15(6):2655-61. doi: 10.7314/apjcp.2014.15.6.2655.
|
| 103 |
Transient receptor potential vanilloid-type 2 targeting on stemness in liver cancer.Biomed Pharmacother. 2018 Sep;105:697-706. doi: 10.1016/j.biopha.2018.06.029. Epub 2018 Jun 12.
|
| 104 |
Amplification of Glyceronephosphate O-Acyltransferase and Recruitment of USP30 Stabilize DRP1 to Promote Hepatocarcinogenesis.Cancer Res. 2018 Oct 15;78(20):5808-5819. doi: 10.1158/0008-5472.CAN-18-0340. Epub 2018 Aug 24.
|
| 105 |
Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide.Neoplasia. 2018 Jun;20(6):594-609. doi: 10.1016/j.neo.2018.02.012. Epub 2018 May 7.
|
| 106 |
miR-424-5p Regulates Hepatoma Cell Proliferation and Apoptosis.Cancer Biother Radiopharm. 2019 Apr;34(3):196-202. doi: 10.1089/cbr.2018.2625. Epub 2019 Jan 24.
|
| 107 |
A comprehensive study of CD44 rs 187115 variant and cancer risk in a central Chinese population.J Cell Biochem. 2019 Aug;120(8):12949-12957. doi: 10.1002/jcb.28566. Epub 2019 Mar 12.
|
| 108 |
Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKK/NF-B pathway.Biochem Biophys Res Commun. 2018 Jun 18;501(1):33-40. doi: 10.1016/j.bbrc.2018.04.116. Epub 2018 May 7.
|
| 109 |
Global gene expression in Ha-ras and B-raf mutated mouse liver tumors.Int J Cancer. 2007 Sep 15;121(6):1382-5. doi: 10.1002/ijc.22801.
|
| 110 |
MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer.Cancer Cell Int. 2018 Apr 3;18:52. doi: 10.1186/s12935-018-0542-y. eCollection 2018.
|
| 111 |
Glycycoumarin Sensitizes Liver Cancer Cells to ABT-737 by Targeting De Novo Lipogenesis and TOPK-Survivin Axis.Nutrients. 2018 Mar 15;10(3):353. doi: 10.3390/nu10030353.
|
| 112 |
Overexpression of SLC7A11: a novel oncogene and an indicator of unfavorable prognosis for liver carcinoma.Future Oncol. 2018 Apr;14(10):927-936. doi: 10.2217/fon-2017-0540. Epub 2018 Mar 12.
|
| 113 |
A novel knowledge-derived data potentizing method revealed unique liver cancer-associated genetic variants.Hum Genomics. 2019 Jul 4;13(1):30. doi: 10.1186/s40246-019-0213-7.
|
| 114 |
Bioinformatic analysis of prognostic value of ZW10 interacting protein in lung cancer.Onco Targets Ther. 2018 Mar 23;11:1683-1695. doi: 10.2147/OTT.S149012. eCollection 2018.
|
| 115 |
Veliparib overcomes multidrug resistance in liver cancer cells.Biochem Biophys Res Commun. 2020 Jan 15;521(3):596-602. doi: 10.1016/j.bbrc.2019.10.141. Epub 2019 Oct 31.
|
| 116 |
Comparative genomics on mammalian Fgf3-Fgf4 locus.Int J Oncol. 2005 Jul;27(1):281-5.
|
| 117 |
Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.Curr Opin Infect Dis. 2008 Jun;21(3):298-303. doi: 10.1097/QCO.0b013e3282fe1bb2.
|
| 118 |
Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.Genes Chromosomes Cancer. 2015 Jan;54(1):51-62. doi: 10.1002/gcc.22218. Epub 2014 Sep 18.
|
| 119 |
Predictive role BLVRA mRNA expression in hepatocellular cancer.Ann Hepatol. 2016 Nov-Dec 2016;15(6):881-887. doi: 10.5604/16652681.1222104.
|
| 120 |
Structure and expression of the cyclin A gene in human primary liver cancer. Correlation with flow cytometric parameters.J Hepatol. 1995 Jul;23(1):47-52. doi: 10.1016/0168-8278(95)80310-6.
|
| 121 |
DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular carcinoma.Am J Pathol. 2011 Feb;178(2):652-61. doi: 10.1016/j.ajpath.2010.10.023.
|
| 122 |
Progenitor gene DLK1 might be an independent prognostic factor of liver cancer.Expert Opin Biol Ther. 2008 Apr;8(4):371-7. doi: 10.1517/14712598.8.4.371.
|
| 123 |
ENSA expression correlates with attenuated tumor propagation in liver cancer.Biochem Biophys Res Commun. 2013 Dec 6;442(1-2):56-61. doi: 10.1016/j.bbrc.2013.10.165. Epub 2013 Nov 8.
|
| 124 |
MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice.Gastroenterology. 2017 Oct;153(4):1120-1132.e15. doi: 10.1053/j.gastro.2016.12.036. Epub 2017 Feb 27.
|
| 125 |
XCL1/Glypican-3 Fusion Gene Immunization Generates Potent Antitumor Cellular Immunity and Enhances Anti-PD-1 Efficacy.Cancer Immunol Res. 2020 Jan;8(1):81-93. doi: 10.1158/2326-6066.CIR-19-0210. Epub 2019 Oct 30.
|
| 126 |
Macrophage-specific hypoxia-inducible factor-1 deletion suppresses the development of liver tumors in high-fat diet-fed obese and diabetic mice.J Diabetes Investig. 2019 Nov;10(6):1411-1418. doi: 10.1111/jdi.13047. Epub 2019 Apr 11.
|
| 127 |
LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis.Cancer Res. 2001 Nov 15;61(22):8079-84.
|
| 128 |
Role of a novel splice variant of mitotic arrest deficient 1 (MAD1), MAD1beta, in mitotic checkpoint control in liver cancer.Cancer Res. 2008 Nov 15;68(22):9194-201. doi: 10.1158/0008-5472.CAN-08-2600.
|
| 129 |
Induction of cytotoxic T lymphocytes from the peripheral blood of a hepatocellular carcinoma patient using melanoma antigen-1 (MAGE-1) peptide.Chin Med J (Engl). 2002 Jul;115(7):1002-5.
|
| 130 |
Musashi 2 contributes to the stemness and chemoresistance of liver cancer stem cells via LIN28A activation.Cancer Lett. 2017 Jan 1;384:50-59. doi: 10.1016/j.canlet.2016.10.007. Epub 2016 Oct 6.
|
| 131 |
Identification of Max binding protein as a novel binding protein of Nck1 and characterization of its role in inhibiting human liver cancer SK-HEP-1 cells.Chin Med J (Engl). 2012 Sep;125(18):3336-9.
|
| 132 |
Identification of three novel cDNAs for human phosphatidylethanolamine N-methyltransferase and localization of the human gene on chromosome 17p11.2.Biochim Biophys Acta. 1999 Jan 4;1436(3):405-12. doi: 10.1016/s0005-2760(98)00147-7.
|
| 133 |
Mutation analysis of novel human liver-related putative tumor suppressor gene in hepatocellular carcinoma.World J Gastroenterol. 2003 Jan;9(1):89-93. doi: 10.3748/wjg.v9.i1.89.
|
| 134 |
Identification of downstream target genes regulated by CX43 in hepatocellular carcinoma.Neoplasma. 2019 Jun 29;66(6):870-878. doi: 10.4149/neo_2018_181225N995. Print 2019 Nov.
|
| 135 |
Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients.J Hepatol. 2003 Oct;39(4):564-70. doi: 10.1016/s0168-8278(03)00355-6.
|
| 136 |
A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility.Oncogene. 2011 Nov 3;30(44):4464-75. doi: 10.1038/onc.2011.161. Epub 2011 May 16.
|
| 137 |
Lupeol, a dietary triterpene, inhibited growth, and induced apoptosis through down-regulation of DR3 in SMMC7721 cells.Cancer Invest. 2009 Feb;27(2):163-70. doi: 10.1080/07357900802210745.
|
| 138 |
DNA topoisomerase 1 and 2A function as oncogenes in liver cancer and may be direct targets of nitidine chloride.Int J Oncol. 2018 Nov;53(5):1897-1912. doi: 10.3892/ijo.2018.4531. Epub 2018 Aug 21.
|
| 139 |
Tripartite motif 24 (Trim24/Tif1) tumor suppressor protein is a novel negative regulator of interferon (IFN)/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor (Rar) inhibition.J Biol Chem. 2011 Sep 23;286(38):33369-79. doi: 10.1074/jbc.M111.225680. Epub 2011 Jul 18.
|
| 140 |
Analysis of aberrant transcription of TSG101 in hepatocellular carcinomas.Eur J Cancer. 1999 Feb;35(2):302-8. doi: 10.1016/s0959-8049(98)00356-6.
|
| 141 |
Statins inhibit expression of thioredoxin reductase 1 in rat and human liver and reduce tumour development.Biochem Biophys Res Commun. 2012 Jan 20;417(3):1046-51. doi: 10.1016/j.bbrc.2011.12.091. Epub 2011 Dec 26.
|
| 142 |
Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma.Epidemiology. 2013 Sep;24(5):671-81. doi: 10.1097/EDE.0b013e31829d2744.
|
| 143 |
Hypercholesterolemia in rats with hepatomas: increased oxysterols accelerate efflux but do not inhibit biosynthesis of cholesterol.Hepatology. 2006 Sep;44(3):602-11. doi: 10.1002/hep.21291.
|
| 144 |
ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population.Cell Mol Life Sci. 2017 Jul;74(13):2513-2524. doi: 10.1007/s00018-017-2472-6. Epub 2017 Feb 20.
|
| 145 |
Differential Expression of Ion Channels and Transporters During Hepatocellular Carcinoma Development.Dig Dis Sci. 2015 Aug;60(8):2373-83. doi: 10.1007/s10620-015-3633-9. Epub 2015 Apr 5.
|
| 146 |
Multiple genes exhibit phenobarbital-induced constitutive active/androstane receptor-mediated DNA methylation changes during liver tumorigenesis and in liver tumors.Toxicol Sci. 2009 Apr;108(2):273-89. doi: 10.1093/toxsci/kfp031. Epub 2009 Feb 20.
|
| 147 |
Methionine adenosyltransferases in cancers: Mechanisms of dysregulation and implications for therapy.Exp Biol Med (Maywood). 2018 Jan;243(2):107-117. doi: 10.1177/1535370217740860. Epub 2017 Nov 15.
|
| 148 |
Development of a novel zebrafish xenograft model in ache mutants using liver cancer cell lines.Sci Rep. 2018 Jan 25;8(1):1570. doi: 10.1038/s41598-018-19817-w.
|
| 149 |
The pleiotropic roles of ADAM9 in the biology of solid tumors.Cell Mol Life Sci. 2018 Jul;75(13):2291-2301. doi: 10.1007/s00018-018-2796-x. Epub 2018 Mar 17.
|
| 150 |
AKR1C1-3, notably AKR1C3, are distinct biomarkers for liver cancer diagnosis and prognosis: Database mining in malignancies.Oncol Lett. 2019 Nov;18(5):4515-4522. doi: 10.3892/ol.2019.10802. Epub 2019 Sep 4.
|
| 151 |
Crosstalk between PTEN/Akt2 and TGFbeta signaling involving EGF receptor down-regulation during the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model.Cancer Sci. 2009 May;100(5):813-20. doi: 10.1111/j.1349-7006.2009.01120.x. Epub 2009 Mar 20.
|
| 152 |
CD166 plays a pro-carcinogenic role in liver cancer cells via inhibition of FOXO proteins through AKT.Oncol Rep. 2014 Aug;32(2):677-83. doi: 10.3892/or.2014.3226. Epub 2014 May 30.
|
| 153 |
Expression levels and prognostic values of annexins in liver cancer.Oncol Lett. 2019 Dec;18(6):6657-6669. doi: 10.3892/ol.2019.11025. Epub 2019 Oct 30.
|
| 154 |
Evaluation of plasma carcinogenic markers in rat hepatic tumors models induced by rat hepatoma N1-S1 cells and benzo[a]pyrene.Arch Pharm Res. 2010 Feb;33(2):247-55. doi: 10.1007/s12272-010-0210-9. Epub 2010 Feb 24.
|
| 155 |
Aquaporin 9 inhibits hepatocellular carcinoma through up-regulating FOXO1 expression.Oncotarget. 2016 Jul 12;7(28):44161-44170. doi: 10.18632/oncotarget.10143.
|
| 156 |
DDEFL1 correlated with Rho GTPases activity in breast cancer.Oncotarget. 2017 Oct 26;8(68):112487-112497. doi: 10.18632/oncotarget.22095. eCollection 2017 Dec 22.
|
| 157 |
MiR-200a inhibits cell proliferation and EMT by down-regulating the ASPH expression levels and affecting ERK and PI3K/Akt pathways in human hepatoma cells.Am J Transl Res. 2018 Apr 15;10(4):1117-1130. eCollection 2018.
|
| 158 |
ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection.Cancer Res Treat. 2015 Oct;47(4):853-61. doi: 10.4143/crt.2014.177. Epub 2015 Feb 16.
|
| 159 |
Overexpression of activating transcription factor 3 exerts suppressive effects in HepG2 cells.Mol Med Rep. 2019 Feb;19(2):869-876. doi: 10.3892/mmr.2018.9707. Epub 2018 Nov 29.
|
| 160 |
Overexpression of Opa interacting protein5 increases the progression of liver cancer via BMPR2/JUN/CHEK1/RAC1 dysregulation.Oncol Rep. 2019 Apr;41(4):2075-2088. doi: 10.3892/or.2019.7006. Epub 2019 Feb 11.
|
| 161 |
Expression of BTG1 in hepatocellular carcinoma and its correlation with cell cycles, cell apoptosis, and cell metastasis.Tumour Biol. 2014 Dec;35(12):11771-9. doi: 10.1007/s13277-014-2298-x. Epub 2014 Aug 31.
|
| 162 |
Elevated expression of complement C3 protein in chemically induced hepatotumorogenesis in Wistar rats: a correlative proteomics and histopathological study.Exp Toxicol Pathol. 2013 Sep;65(6):767-73. doi: 10.1016/j.etp.2012.11.003. Epub 2012 Dec 12.
|
| 163 |
Increased incidence of CAD gene amplification in tumorigenic rat lines as an indicator of genomic instability of neoplastic cells.J Biol Chem. 1989 Feb 25;264(6):3390-6.
|
| 164 |
The camKK2/camKIV relay is an essential regulator of hepatic cancer.Hepatology. 2015 Aug;62(2):505-20. doi: 10.1002/hep.27832. Epub 2015 May 9.
|
| 165 |
AMPK-ERK/CARM1 Signaling Pathways Affect Autophagy of Hepatic Cells in Samples of Liver Cancer Patients.Front Oncol. 2019 Nov 14;9:1247. doi: 10.3389/fonc.2019.01247. eCollection 2019.
|
| 166 |
Chloroquine upregulates TRAIL/TRAILR2 expression and potentiates doxorubicin anti-tumor activity in thioacetamide-induced hepatocellular carcinoma model.Chem Biol Interact. 2018 Jan 5;279:84-94. doi: 10.1016/j.cbi.2017.11.009. Epub 2017 Nov 10.
|
| 167 |
Effects of melanoma differentiation associated gene-7 (MDA-7/IL-24) on apoptosis of liver cancer cells via regulating the expression of B-cell lymphoma-2.Oncol Lett. 2019 Jul;18(1):29-34. doi: 10.3892/ol.2019.10298. Epub 2019 May 2.
|
| 168 |
MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1.Cancer Cell Int. 2019 Jan 14;19:15. doi: 10.1186/s12935-019-0729-x. eCollection 2019.
|
| 169 |
CCND1 silencing suppresses liver cancer stem cell differentiation through inhibiting autophagy.Hum Cell. 2020 Jan;33(1):140-147. doi: 10.1007/s13577-019-00295-9. Epub 2019 Oct 30.
|
| 170 |
CC chemokine receptor type2 promotes epithelialtomesenchymal transition by upregulating matrix metalloproteinase? in human liver cancer.Oncol Rep. 2018 Nov;40(5):2734-2741. doi: 10.3892/or.2018.6660. Epub 2018 Aug 17.
|
| 171 |
Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma.Hepatology. 2019 Jul;70(1):168-183. doi: 10.1002/hep.30347. Epub 2019 Mar 5.
|
| 172 |
CpG site hypermethylation of E-cadherin and Connexin26 genes in hepatocellular carcinomas induced by a choline-deficient L-Amino Acid-defined diet in rats.Mol Carcinog. 2007 Apr;46(4):269-74. doi: 10.1002/mc.20268.
|
| 173 |
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC.Gut. 2009 May;58(5):679-87. doi: 10.1136/gut.2008.152652. Epub 2009 Jan 9.
|
| 174 |
miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1.Mol Ther Nucleic Acids. 2018 Jun 1;11:494-507. doi: 10.1016/j.omtn.2018.04.001. Epub 2018 Apr 12.
|
| 175 |
Inhibition of S-phase kinase-associated protein 2-mediated p27 degradation suppresses tumorigenesis and the progression of hepatocellular carcinoma.Mol Med Rep. 2015 May;11(5):3934-40. doi: 10.3892/mmr.2015.3156. Epub 2015 Jan 8.
|
| 176 |
Evaluation of Relationship between Occurrence of Liver Cancer and Methylation of Fragile Histidine Triad (FHIT) and P16 Genes.Med Sci Monit. 2019 Feb 18;25:1301-1306. doi: 10.12659/MSM.912315.
|
| 177 |
Persistent elevation of carcinoembryonic antigen as first presentation of a medullary thyroid carcinoma.BMJ Case Rep. 2018 Jun 11;2018:bcr2017223233. doi: 10.1136/bcr-2017-223233.
|
| 178 |
Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer.Oncogene. 2018 Jun;37(24):3216-3228. doi: 10.1038/s41388-018-0126-2. Epub 2018 Mar 7.
|
| 179 |
A tumor-penetrating peptide modification enhances the antitumor activity of endostatin in vivo.Anticancer Drugs. 2011 Jun;22(5):409-15. doi: 10.1097/CAD.0b013e328342050d.
|
| 180 |
Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action.PLoS One. 2014 Jul 24;9(7):e102579. doi: 10.1371/journal.pone.0102579. eCollection 2014.
|
| 181 |
Combined GM-CSF and IL-12 gene therapy synergistically suppresses the growth of orthotopic liver tumors.Hepatology. 2007 Mar;45(3):746-54. doi: 10.1002/hep.21560.
|
| 182 |
Neurobiochemical changes from Taxol/Neupogen chemotherapy for metastatic breast carcinoma corresponds with suicidal depression.Cancer Lett. 1996 Dec 20;110(1-2):163-7. doi: 10.1016/s0304-3835(96)04486-2.
|
| 183 |
Reduced C-terminal Src kinase (Csk) activities in hepatocellular carcinoma.Hepatology. 1999 Feb;29(2):379-84. doi: 10.1002/hep.510290239.
|
| 184 |
SCP1 regulates c-Myc stability and functions through dephosphorylating c-Myc Ser62.Oncogene. 2016 Jan 28;35(4):491-500. doi: 10.1038/onc.2015.106. Epub 2015 Apr 20.
|
| 185 |
Reciprocal Regulation Between O-GlcNAcylation and -Catenin Facilitates Cell Viability and Inhibits Apoptosis in Liver Cancer.DNA Cell Biol. 2019 Apr;38(4):286-296. doi: 10.1089/dna.2018.4447. Epub 2019 Feb 14.
|
| 186 |
The cycloartane triterpenoid ADCX impairs autophagic degradation through Akt overactivation and promotes apoptotic cell death in multidrug-resistant HepG2/ADM cells.Biochem Pharmacol. 2017 Dec 15;146:87-100. doi: 10.1016/j.bcp.2017.10.012. Epub 2017 Oct 24.
|
| 187 |
Effect of vitamin E and human placenta cysteine peptidase inhibitor on expression of cathepsins B and L in implanted hepatoma Morris 5123 tumor model in Wistar rats.World J Gastroenterol. 2005 Jan 28;11(4):587-92. doi: 10.3748/wjg.v11.i4.587.
|
| 188 |
The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cells.J Clin Invest. 2010 Nov;120(11):3820-33. doi: 10.1172/JCI41959. Epub 2010 Oct 11.
|
| 189 |
CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells.Eur J Cancer. 2012 Jan;48(1):138-48. doi: 10.1016/j.ejca.2011.06.044. Epub 2011 Jul 19.
|
| 190 |
An alternatively spliced variant of CXCR3 mediates the metastasis of CD133+ liver cancer cells induced by CXCL9.Oncotarget. 2016 Mar 22;7(12):14405-14. doi: 10.18632/oncotarget.7360.
|
| 191 |
Meta-analysis of CYP2E1 polymorphisms in liver carcinogenesis.Dig Liver Dis. 2017 Jan;49(1):77-83. doi: 10.1016/j.dld.2016.08.114. Epub 2016 Aug 18.
|
| 192 |
Tumor-specific inhibitory action of decorin on different hepatoma cell lines.Cell Signal. 2019 Oct;62:109354. doi: 10.1016/j.cellsig.2019.109354. Epub 2019 Jul 2.
|
| 193 |
Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3/p-Tyr216-GSK-3/-catenin axis.Oncol Rep. 2017 Aug;38(2):1035-1042. doi: 10.3892/or.2017.5721. Epub 2017 Jun 14.
|
| 194 |
DEP domain containing 1 suppresses apoptosis via inhibition of A20 expression, which activates the nuclear factor B signaling pathway in HepG2 cells.Oncol Lett. 2018 Jul;16(1):949-955. doi: 10.3892/ol.2018.8770. Epub 2018 May 22.
|
| 195 |
Absence of mature microRNAs inactivates the response of gene expression to carcinogenesis induced by N-ethyl-N-nitrosourea in mouse liver.J Appl Toxicol. 2014 Dec;34(12):1409-17. doi: 10.1002/jat.2973. Epub 2014 Jan 30.
|
| 196 |
Recent Progress of Wnt Pathway Inhibitor Dickkopf-1 in Liver Cancer.J Nanosci Nanotechnol. 2018 Aug 1;18(8):5192-5206. doi: 10.1166/jnn.2018.14636.
|
| 197 |
Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma.Sci Rep. 2017 Mar 17;7:44653. doi: 10.1038/srep44653.
|
| 198 |
LncRNA SNHG1 promotes liver cancer development through inhibiting p53 expression via binding to DNMT1.Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2768-2776. doi: 10.26355/eurrev_201904_17550.
|
| 199 |
miR-639 Expression Is Silenced by DNMT3A-Mediated Hypermethylation and Functions as a Tumor Suppressor in Liver Cancer Cells.Mol Ther. 2020 Feb 5;28(2):587-598. doi: 10.1016/j.ymthe.2019.11.021. Epub 2019 Nov 28.
|
| 200 |
Role of de novo DNA methyltransferases and methyl CpG-binding proteins in gene silencing in a rat hepatoma.J Biol Chem. 2002 May 3;277(18):16048-58. doi: 10.1074/jbc.M111662200. Epub 2002 Feb 13.
|
| 201 |
Novel 1,4-dihydropyridine induces apoptosis in human cancer cells through overexpression of Sirtuin1.Apoptosis. 2018 Oct;23(9-10):532-553. doi: 10.1007/s10495-018-1483-6.
|
| 202 |
Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer.Cancer Lett. 2019 Jun 1;451:100-109. doi: 10.1016/j.canlet.2019.02.046. Epub 2019 Mar 6.
|
| 203 |
LncRNA ZEB1-AS1 reduces liver cancer cell proliferation by targeting miR-365a-3p.Exp Ther Med. 2019 May;17(5):3539-3547. doi: 10.3892/etm.2019.7358. Epub 2019 Mar 7.
|
| 204 |
PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells.J Biomed Sci. 2010 May 6;17(1):35. doi: 10.1186/1423-0127-17-35.
|
| 205 |
Hepatitis C Virus Core Protein Modulates Endoglin (CD105) Signaling Pathway for Liver Pathogenesis.J Virol. 2017 Oct 13;91(21):e01235-17. doi: 10.1128/JVI.01235-17. Print 2017 Nov 1.
|
| 206 |
Is autotaxin (ENPP2) the link between hepatitis C and hepatocellular cancer?.J Gastrointest Surg. 2007 Dec;11(12):1628-34; discussion 1634-5. doi: 10.1007/s11605-007-0322-9. Epub 2007 Sep 25.
|
| 207 |
Histone acetyltransferase MOZ acts as a co-activator of Nrf2-MafK and induces tumour marker gene expression during hepatocarcinogenesis.Biochem J. 2007 Mar 15;402(3):559-66. doi: 10.1042/BJ20061194.
|
| 208 |
Biosynthesis of Silver Nanoparticles Mediated by Extracellular Pigment from Talaromyces purpurogenus and Their Biomedical Applications.Nanomaterials (Basel). 2019 Jul 21;9(7):1042. doi: 10.3390/nano9071042.
|
| 209 |
The Delta Subunit of Rod-Specific Photoreceptor cGMP Phosphodiesterase (PDE6D) Contributes to Hepatocellular Carcinoma Progression.Cancers (Basel). 2019 Mar 21;11(3):398. doi: 10.3390/cancers11030398.
|
| 210 |
EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression.Exp Mol Med. 2019 Jun 3;51(6):1-12. doi: 10.1038/s12276-019-0261-z.
|
| 211 |
Trans-acting non-synonymous variant of FOXA1 predisposes to hepatocellular carcinoma through modulating FOXA1-ER transcriptional program and may have undergone natural selection.Carcinogenesis. 2020 Apr 22;41(2):146-158. doi: 10.1093/carcin/bgz136.
|
| 212 |
Estrogen-related receptor is upregulated in liver cancer and its inhibition suppresses liver cancer cell proliferation via induction of p21 and p27.Exp Mol Med. 2016 Mar 4;48(3):e213. doi: 10.1038/emm.2015.115.
|
| 213 |
Samsum Ant Venom Exerts Anticancer Activity Through Immunomodulation In Vitro and In Vivo.Cancer Biother Radiopharm. 2018 Mar;33(2):65-73. doi: 10.1089/cbr.2017.2400.
|
| 214 |
FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer.Mol Cancer Ther. 2019 Dec;18(12):2194-2206. doi: 10.1158/1535-7163.MCT-18-1291. Epub 2019 Aug 13.
|
| 215 |
Correction: SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer.PLoS Genet. 2018 Apr 11;14(4):e1007344. doi: 10.1371/journal.pgen.1007344. eCollection 2018 Apr.
|
| 216 |
Association of FHIT expression and FHIT gene hypermethylation with liver cancer risk: a PRISMA-compliant meta-analysis.Onco Targets Ther. 2017 Jun 20;10:3083-3093. doi: 10.2147/OTT.S138036. eCollection 2017.
|
| 217 |
Epigenetic analysis of FHL1 tumor suppressor gene in human liver cancer. Oncol Lett. 2017 Nov;14(5):6109-6116.
|
| 218 |
Molecular mechanisms of nano-selenium in mitigating hepatocellular carcinoma induced by N-nitrosodiethylamine (NDEA) in rats.Toxicol Mech Methods. 2014 Dec;24(8):593-602. doi: 10.3109/15376516.2014.956912. Epub 2014 Sep 4.
|
| 219 |
Follistatin overexpression in rodent liver tumors: a possible mechanism to overcome activin growth control.Mol Carcinog. 2002 Sep;35(1):1-5. doi: 10.1002/mc.10068.
|
| 220 |
Rat ferritin-H: cDNA cloning, differential expression and localization during hepatocarcinogenesis.Carcinogenesis. 1997 Jan;18(1):47-52. doi: 10.1093/carcin/18.1.47.
|
| 221 |
The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer.Sci Rep. 2018 Jun 14;8(1):9105. doi: 10.1038/s41598-018-27358-5.
|
| 222 |
Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. Am J Pathol. 2003 Jun;162(6):1961-74.
|
| 223 |
MAP4K3/GLK in autoimmune disease, cancer and aging.J Biomed Sci. 2019 Oct 22;26(1):82. doi: 10.1186/s12929-019-0570-5.
|
| 224 |
Rapidly quantitative analysis of -glutamyltranspeptidase activity in the lysate and blood via a rational design of the molecular probe by matrix-assisted laser desorption ionization mass spectrometry.Talanta. 2019 Dec 1;205:120141. doi: 10.1016/j.talanta.2019.120141. Epub 2019 Jul 9.
|
| 225 |
Changes in gap junction protein (connexin 32) gene expression during rat liver carcinogenesis.J Cell Biochem. 1989 Oct;41(2):97-102. doi: 10.1002/jcb.240410206.
|
| 226 |
Proteomic Analysis Reveals GMP Synthetase as p53 Repression Target in Liver Cancer.Am J Pathol. 2017 Feb;187(2):228-235. doi: 10.1016/j.ajpath.2016.09.022. Epub 2016 Dec 7.
|
| 227 |
Platelet GPIb is a mediator and potential interventional target for NASH and subsequent liver cancer.Nat Med. 2019 Apr;25(4):641-655. doi: 10.1038/s41591-019-0379-5. Epub 2019 Apr 1.
|
| 228 |
Development of Inflammatory Immune Response-Related Drugs Based on G Protein-Coupled Receptor Kinase 2.Cell Physiol Biochem. 2018;51(2):729-745. doi: 10.1159/000495329. Epub 2018 Nov 21.
|
| 229 |
Novel biomarkers GEP/ABCB5 regulate response to adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma.Hepatobiliary Pancreat Dis Int. 2018 Dec;17(6):524-530. doi: 10.1016/j.hbpd.2018.10.003. Epub 2018 Oct 29.
|
| 230 |
Hepcidin and DNA promoter methylation in hepatocellular carcinoma.Eur J Clin Invest. 2018 Feb;48(2):e12870. doi: 10.1111/eci.12870. Epub 2017 Dec 28.
|
| 231 |
Inhibition of histone deacetylase 11 promotes human liver cancer cell apoptosis.Am J Transl Res. 2019 Feb 15;11(2):983-990. eCollection 2019.
|
| 232 |
HDAC3 Deficiency Promotes Liver Cancer through a Defect in H3K9ac/H3K9me3 Transition.Cancer Res. 2019 Jul 15;79(14):3676-3688. doi: 10.1158/0008-5472.CAN-18-3767. Epub 2019 May 16.
|
| 233 |
Effect of hepatocyte growth factor on methionine adenosyltransferase genes and growth is cell density-dependent in HepG2 cells. J Cell Physiol. 2007 Mar;210(3):766-73.
|
| 234 |
HGFAC expression decreased in liver cancer and its low expression correlated with DNA hypermethylation and poor prognosis.J Cell Biochem. 2019 Jun;120(6):9692-9699. doi: 10.1002/jcb.28247. Epub 2019 Jan 11.
|
| 235 |
miR-885-5p Negatively Regulates Warburg Effect by Silencing Hexokinase 2 in Liver Cancer.Mol Ther Nucleic Acids. 2019 Dec 6;18:308-319. doi: 10.1016/j.omtn.2019.09.002. Epub 2019 Sep 12.
|
| 236 |
Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyrias.J Hepatol. 2015 Mar;62(3):734-8. doi: 10.1016/j.jhep.2014.11.029. Epub 2014 Nov 28.
|
| 237 |
Adenovirus-Mediated Delivery of Decoy Hyper Binding Sites Targeting Oncogenic HMGA1 Reduces Pancreatic and Liver Cancer Cell Viability.Mol Ther Oncolytics. 2018 Jan 31;8:52-61. doi: 10.1016/j.omto.2018.01.002. eCollection 2018 Mar 30.
|
| 238 |
HMGCS2 Mediates Ketone Production and Regulates the Proliferation and Metastasis of Hepatocellular Carcinoma.Cancers (Basel). 2019 Nov 26;11(12):1876. doi: 10.3390/cancers11121876.
|
| 239 |
Heme oxygenase-1 as a potential therapeutic target for hepatoprotection.J Biochem Mol Biol. 2006 Sep 30;39(5):479-91. doi: 10.5483/bmbrep.2006.39.5.479.
|
| 240 |
The impact of hepatocyte nuclear factor-1 on liver malignancies and cell stemness with metabolic consequences.Stem Cell Res Ther. 2019 Nov 4;10(1):315. doi: 10.1186/s13287-019-1438-z.
|
| 241 |
Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development.RNA. 2014 Apr;20(4):505-15. doi: 10.1261/rna.042259.113. Epub 2014 Feb 26.
|
| 242 |
Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors.Cancer Res. 2013 Jul 1;73(13):3974-86. doi: 10.1158/0008-5472.CAN-12-3824. Epub 2013 Apr 30.
|
| 243 |
Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.Lancet. 1992 Oct 3;340(8823):813-7. doi: 10.1016/0140-6736(92)92685-9.
|
| 244 |
17hydroxysteroid dehydrogenase4 induces liver cancer proliferationassociated genes via STAT3 activation.Oncol Rep. 2019 Mar;41(3):2009-2019. doi: 10.3892/or.2019.6981. Epub 2019 Jan 23.
|
| 245 |
Glucose-regulated protein of 94 kDa contributes to the development of an aggressive phenotype in breast cancer cells.Biomed Pharmacother. 2018 Sep;105:115-120. doi: 10.1016/j.biopha.2018.05.106. Epub 2018 May 28.
|
| 246 |
Expression of mortalin detected in human liver cancer by tissue microarrays.Anat Rec (Hoboken). 2011 Aug;294(8):1344-51. doi: 10.1002/ar.21433. Epub 2011 Jun 28.
|
| 247 |
SUMOylation of HSP27 by small ubiquitin-like modifier 2/3 promotes proliferation and invasion of hepatocellular carcinoma cells.Cancer Biol Ther. 2017 Aug 3;18(8):552-559. doi: 10.1080/15384047.2017.1345382. Epub 2017 Jun 30.
|
| 248 |
The influence of interleukin 28B polymorphisms on the risk of hepatocellular carcinoma among patients with HBV or HCV infection: An updated meta-analysis.Medicine (Baltimore). 2019 Sep;98(38):e17275. doi: 10.1097/MD.0000000000017275.
|
| 249 |
Changes in the antioxidant defense and hepatic drug metabolizing enzyme and isoenzyme levels, 8-hydroxydeoxyguanosine formation and expressions of c-raf.1 and insulin-like growth factor II genes during the stages of development of hepatocellular carcinoma in rats.Eur J Cancer Prev. 2007 Aug;16(4):363-71. doi: 10.1097/01.cej.0000236254.01608.33.
|
| 250 |
Cytokine augments the sorafenib-induced apoptosis in Huh7 liver cancer cell by inducing mitochondrial fragmentation and activating MAPK-JNK signalling pathway.Biomed Pharmacother. 2019 Feb;110:213-223. doi: 10.1016/j.biopha.2018.11.037. Epub 2018 Nov 23.
|
| 251 |
The beta secretase BACE1 regulates the expression of insulin receptor in the liver.Nat Commun. 2018 Apr 3;9(1):1306. doi: 10.1038/s41467-018-03755-2.
|
| 252 |
Insulin receptor substrate 2: a bridge between Hippo and AKT pathways.BMB Rep. 2018 May;51(5):209-210. doi: 10.5483/bmbrep.2018.51.5.095.
|
| 253 |
LSD1 Stimulates Cancer-Associated Fibroblasts to Drive Notch3-Dependent Self-Renewal of Liver Cancer Stem-like Cells.Cancer Res. 2018 Feb 15;78(4):938-949. doi: 10.1158/0008-5472.CAN-17-1236. Epub 2017 Dec 19.
|
| 254 |
Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance.Oncotarget. 2016 Jun 28;7(26):39931-39944. doi: 10.18632/oncotarget.9539.
|
| 255 |
Ubiquitin E3 ligase SCF(-TRCP) regulates TRIB2 stability in liver cancer cells.Biochem Biophys Res Commun. 2013 Nov 22;441(3):555-9. doi: 10.1016/j.bbrc.2013.10.123. Epub 2013 Nov 5.
|
| 256 |
High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer.Oncoimmunology. 2016 Dec 7;6(1):e1264562. doi: 10.1080/2162402X.2016.1264562. eCollection 2017.
|
| 257 |
AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity.Mol Oncol. 2018 Mar;12(3):373-390. doi: 10.1002/1878-0261.12171. Epub 2018 Feb 6.
|
| 258 |
Anti-tumor effect of LATS2 on liver cancer death: Role of DRP1-mediated mitochondrial division and the Wnt/-catenin pathway.Biomed Pharmacother. 2019 Jun;114:108825. doi: 10.1016/j.biopha.2019.108825. Epub 2019 Apr 11.
|
| 259 |
Machilin A Inhibits Tumor Growth and Macrophage M2 Polarization Through the Reduction of Lactic Acid.Cancers (Basel). 2019 Jul 9;11(7):963. doi: 10.3390/cancers11070963.
|
| 260 |
Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5(+) liver cancer initiating cells by suppressing negative regulators of -catenin signaling.Oncogene. 2015 Jun 11;34(24):3188-98. doi: 10.1038/onc.2015.129. Epub 2015 Apr 20.
|
| 261 |
Frequent mutations of lysophosphatidic acid receptor-1 gene in rat liver tumors.Mutat Res. 2009 Jan 15;660(1-2):47-50. doi: 10.1016/j.mrfmmm.2008.10.005. Epub 2008 Oct 21.
|
| 262 |
Down-regulation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats.Jpn J Cancer Res. 2002 Jun;93(6):616-25. doi: 10.1111/j.1349-7006.2002.tb01299.x.
|
| 263 |
MAGEC2 Correlates With Unfavorable Prognosis And Promotes Tumor Development In HCC Via Epithelial-Mesenchymal Transition.Onco Targets Ther. 2019 Sep 24;12:7843-7855. doi: 10.2147/OTT.S213164. eCollection 2019.
|
| 264 |
Mesencephalic Astrocyte-Derived Neurotrophic Factor Inhibits Liver Cancer Through Small Ubiquitin-Related Modifier (SUMO)ylation-Related Suppression of NF-B/Snail Signaling Pathway and Epithelial-Mesenchymal Transition.Hepatology. 2020 Apr;71(4):1262-1278. doi: 10.1002/hep.30917. Epub 2020 Jan 26.
|
| 265 |
Prognostic impact of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation in patients with unresectable hepatocellular carcinoma: Comparison with TACE alone using decision-tree analysis after propensity score matching.Hepatol Res. 2019 Aug;49(8):919-928. doi: 10.1111/hepr.13348. Epub 2019 May 13.
|
| 266 |
miR-302a inhibits human HepG2 and SMMC-7721 cells proliferation and promotes apoptosis by targeting MAP3K2 and PBX3.Sci Rep. 2019 Feb 14;9(1):2032. doi: 10.1038/s41598-018-38435-0.
|
| 267 |
Hepatitis B Virus X Protein Induces SATB1 Expression Through Activation of ERK and p38MAPK Pathways to Suppress Anoikis.Dig Dis Sci. 2019 Nov;64(11):3203-3214. doi: 10.1007/s10620-019-05681-9. Epub 2019 May 30.
|
| 268 |
Withdrawal:The long noncoding RNA lncZic2 drives the self-renewal of liver tumor-initiating cells via the protein kinase C substrates MARCKS and MARCKSL1.J Biol Chem. 2018 May 25;293(21):7982-7992. doi: 10.1074/jbc.RA117.001321. Epub 2018 Mar 27.
|
| 269 |
Polyamine and methionine adenosyltransferase 2A crosstalk in human colon and liver cancer.Exp Cell Res. 2013 Jul 15;319(12):1902-1911. doi: 10.1016/j.yexcr.2013.04.005. Epub 2013 Apr 12.
|
| 270 |
miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.World J Gastroenterol. 2016 Jun 14;22(22):5183-92. doi: 10.3748/wjg.v22.i22.5183.
|
| 271 |
Increased expression of neprilysin (neutral endopeptidase 24.11) in rat and human hepatocellular carcinomas.Lab Invest. 1994 Jan;70(1):107-13.
|
| 272 |
Sulfatase-1 knockdown promotes in vitro and in vivo aggressive behavior of murine hepatocarcinoma Hca-P cells through up-regulation of mesothelin.J Cell Commun Signal. 2018 Sep;12(3):603-613. doi: 10.1007/s12079-017-0411-9. Epub 2017 Dec 23.
|
| 273 |
Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.Tumour Biol. 2016 May;37(5):5885-95. doi: 10.1007/s13277-015-4456-1. Epub 2015 Nov 21.
|
| 274 |
Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer.Int J Cancer. 2011 Nov 1;129(9):2256-62. doi: 10.1002/ijc.25870. Epub 2011 Apr 8.
|
| 275 |
NELFE-Dependent MYC Signature Identifies a Unique Cancer Subtype in Hepatocellular Carcinoma.Sci Rep. 2019 Mar 4;9(1):3369. doi: 10.1038/s41598-019-39727-9.
|
| 276 |
Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid.Proc Natl Acad Sci U S A. 2018 May 8;115(19):4969-4974. doi: 10.1073/pnas.1802279115. Epub 2018 Apr 23.
|
| 277 |
Protective effects of glycycoumarin on liver diseases.Phytother Res. 2020 Jun;34(6):1191-1197. doi: 10.1002/ptr.6598. Epub 2019 Dec 16.
|
| 278 |
A Novel Small Molecule Activator of Nuclear Receptor SHP Inhibits HCC Cell Migration via Suppressing Ccl2.Mol Cancer Ther. 2016 Oct;15(10):2294-2301. doi: 10.1158/1535-7163.MCT-16-0153. Epub 2016 Aug 2.
|
| 279 |
Role of Farnesoid X Receptor and Bile Acids in Hepatic Tumor Development.Hepatol Commun. 2018 Oct 1;2(12):1567-1582. doi: 10.1002/hep4.1263. eCollection 2018 Dec.
|
| 280 |
High-Content Analysis of Constitutive Androstane Receptor Nuclear Translocation.Methods Mol Biol. 2019;1966:71-77. doi: 10.1007/978-1-4939-9195-2_6.
|
| 281 |
MiR-204 inhibits hepatocellular cancer drug resistance and metastasis through targeting NUAK1.Biochem Cell Biol. 2019 Oct;97(5):563-570. doi: 10.1139/bcb-2018-0354. Epub 2019 Feb 26.
|
| 282 |
Mechanism of Inactivation of Ornithine Aminotransferase by (1S,3S)-3-Amino-4-(hexafluoropropan-2-ylidenyl)cyclopentane-1-carboxylic Acid.J Am Chem Soc. 2019 Jul 10;141(27):10711-10721. doi: 10.1021/jacs.9b03254. Epub 2019 Jun 28.
|
| 283 |
The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer.Am J Physiol Regul Integr Comp Physiol. 2010 Feb;298(2):R459-66. doi: 10.1152/ajpregu.00646.2009. Epub 2009 Nov 18.
|
| 284 |
Effective Combined Photodynamic Therapy with Lipid Platinum Chloride Nanoparticles Therapies of Oral Squamous Carcinoma Tumor Inhibition.J Clin Med. 2019 Dec 2;8(12):2112. doi: 10.3390/jcm8122112.
|
| 285 |
TPP-related mitochondrial targeting copper (II) complex induces p53-dependent apoptosis in hepatoma cells through ROS-mediated activation of Drp1.Cell Commun Signal. 2019 Nov 19;17(1):149. doi: 10.1186/s12964-019-0468-6.
|
| 286 |
Programmed cell death-1 in patients with primary liver cancer and its effect on prognosis.J BUON. 2019 May-Jun;24(3):1167-1174.
|
| 287 |
PDCD2 sensitizes HepG2 cells to sorafenib by suppressing epithelialmesenchymal transition.Mol Med Rep. 2019 Mar;19(3):2173-2179. doi: 10.3892/mmr.2019.9860. Epub 2019 Jan 15.
|
| 288 |
Can Prohibitin 1 be a Safeguard against liver disease?.Ann Hepatol. 2019 Nov-Dec;18(6):790-795. doi: 10.1016/j.aohep.2019.07.012. Epub 2019 Sep 11.
|
| 289 |
Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models.Toxicol Appl Pharmacol. 2017 Mar 1;318:79-87. doi: 10.1016/j.taap.2017.01.006. Epub 2017 Jan 18.
|
| 290 |
Synergy of urokinasetype plasminogen activator receptor isomer (D1D2) and integrin 51 causes malignant transformation of hepatic cells and the occurrence of liver cancer.Mol Med Rep. 2014 Nov;10(5):2568-74. doi: 10.3892/mmr.2014.2503. Epub 2014 Aug 20.
|
| 291 |
Comprehensive and Integrative Analysis Reveals the Diagnostic, Clinicopathological and Prognostic Significance of Polo-Like Kinase 1 in Hepatocellular Carcinoma.Cell Physiol Biochem. 2018;47(3):925-947. doi: 10.1159/000490135. Epub 2018 May 24.
|
| 292 |
Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma.Hepatology. 2010 Mar;51(3):857-68. doi: 10.1002/hep.23467.
|
| 293 |
A cis-eQTL genetic variant in PLK4 confers high risk of hepatocellular carcinoma.Cancer Med. 2019 Oct;8(14):6476-6484. doi: 10.1002/cam4.2487. Epub 2019 Sep 6.
|
| 294 |
Tumor endothelial marker 7 (TEM-7): a novel target for antiangiogenic therapy.Microvasc Res. 2011 Nov;82(3):253-62. doi: 10.1016/j.mvr.2011.09.004. Epub 2011 Sep 17.
|
| 295 |
Keratin 23 Is a Peroxisome Proliferator-Activated Receptor Alpha-Dependent, MYC-Amplified Oncogene That Promotes Hepatocyte Proliferation.Hepatology. 2019 Jul;70(1):154-167. doi: 10.1002/hep.30530. Epub 2019 Mar 20.
|
| 296 |
Sestrin2 facilitates glutamine-dependent transcription of PGC-1 and survival of liver cancer cells under glucose limitation.FEBS J. 2018 Apr;285(7):1326-1345. doi: 10.1111/febs.14406. Epub 2018 Mar 8.
|
| 297 |
Enzymic capacities of purine de Novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues.Cancer Res. 1984 Jun;44(6):2475-9.
|
| 298 |
The Oncoprotein Gankyrin/PSMD10 as a Target of Cancer Therapy.Adv Exp Med Biol. 2019;1164:63-71. doi: 10.1007/978-3-030-22254-3_5.
|
| 299 |
RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts.Oncogene. 2004 Jul 29;23(34):5815-22. doi: 10.1038/sj.onc.1207773.
|
| 300 |
Prostaglandin E2 promotes human cholangiocarcinoma cell proliferation, migration and invasion through the upregulation of -catenin expression via EP3-4 receptor.Oncol Rep. 2015 Aug;34(2):715-26. doi: 10.3892/or.2015.4043. Epub 2015 Jun 9.
|
| 301 |
Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.Oncotarget. 2015 Jun 20;6(17):15050-64. doi: 10.18632/oncotarget.3670.
|
| 302 |
Receptor for activated protein kinase C: requirement for efficient microRNA function and reduced expression in hepatocellular carcinoma.PLoS One. 2011;6(9):e24359. doi: 10.1371/journal.pone.0024359. Epub 2011 Sep 15.
|
| 303 |
Internal radiotherapy of liver cancer with rat hepatocarcinoma-intestine-pancreas gene as a liver tumor-specific promoter.Hum Gene Ther. 2008 Sep;19(9):915-26. doi: 10.1089/hum.2007.153.
|
| 304 |
Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.Cancer Res. 2005 Oct 1;65(19):8861-8. doi: 10.1158/0008-5472.CAN-05-1318.
|
| 305 |
RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer.Cancer Cell. 2017 Jan 9;31(1):94-109. doi: 10.1016/j.ccell.2016.11.009. Epub 2016 Dec 22.
|
| 306 |
Genistein-triggered anticancer activity against liver cancer cell line HepG2 involves ROS generation, mitochondrial apoptosis, G2/M cell cycle arrest and inhibition of cell migration.Arch Med Sci. 2019 Jul;15(4):1001-1009. doi: 10.5114/aoms.2018.78742. Epub 2018 Oct 3.
|
| 307 |
The phosphorylation of SEPT2 on Ser218 by casein kinase 2 is important to hepatoma carcinoma cell proliferation.Mol Cell Biochem. 2009 May;325(1-2):61-7. doi: 10.1007/s11010-008-0020-2. Epub 2009 Jan 23.
|
| 308 |
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity.Sci Rep. 2015 Dec 4;5:17701. doi: 10.1038/srep17701.
|
| 309 |
Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.Int J Oncol. 2006 Aug;29(2):315-27.
|
| 310 |
Loss of metallothionein predisposes mice to diethylnitrosamine-induced hepatocarcinogenesis by activating NF-kappaB target genes.Cancer Res. 2010 Dec 15;70(24):10265-76. doi: 10.1158/0008-5472.CAN-10-2839.
|
| 311 |
Histone deacetylase SIRT6 regulates chemosensitivity in liver cancer cells via modulation of FOXO3 activity.Oncol Rep. 2018 Dec;40(6):3635-3644. doi: 10.3892/or.2018.6770. Epub 2018 Oct 8.
|
| 312 |
Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors.Sci Rep. 2017 Apr 4;7(1):641. doi: 10.1038/s41598-017-00219-3.
|
| 313 |
Sorafenib Activity and Disposition in Liver Cancer Does Not Depend on Organic Cation Transporter 1.Clin Pharmacol Ther. 2020 Jan;107(1):227-237. doi: 10.1002/cpt.1588. Epub 2019 Sep 3.
|
| 314 |
Oncoprotein LAMTOR5 Activates GLUT1 Via Upregulating NF-B in Liver Cancer.Open Med (Wars). 2019 Feb 26;14:264-270. doi: 10.1515/med-2019-0022. eCollection 2019.
|
| 315 |
Rhesus monkey model of liver disease reflecting clinical disease progression and hepatic gene expression analysis.Sci Rep. 2015 Oct 7;5:15019. doi: 10.1038/srep15019.
|
| 316 |
Chronic administration of 2-acetylaminofluorene alters the cellular iron metabolism in rat liver.Toxicol Sci. 2011 Oct;123(2):433-40. doi: 10.1093/toxsci/kfr193. Epub 2011 Jul 23.
|
| 317 |
Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake.Int J Cancer. 2018 Apr 15;142(8):1712-1722. doi: 10.1002/ijc.31193. Epub 2017 Dec 12.
|
| 318 |
Dual-targeted NIS polyplexes-a theranostic strategy toward tumors with heterogeneous receptor expression.Gene Ther. 2019 Apr;26(3-4):93-108. doi: 10.1038/s41434-019-0059-6. Epub 2019 Jan 25.
|
| 319 |
Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth.Int J Mol Sci. 2018 Jul 19;19(7):2093. doi: 10.3390/ijms19072093.
|
| 320 |
Expression of OATP family members in hormone-related cancers: potential markers of progression.PLoS One. 2011;6(5):e20372. doi: 10.1371/journal.pone.0020372. Epub 2011 May 19.
|
| 321 |
Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration.Int J Oncol. 2006 May;28(5):1081-8.
|
| 322 |
p62 functions as an oncogene in colorectal cancer through inhibiting apoptosis and promoting cell proliferation by interacting with the vitamin D receptor.Cell Prolif. 2019 May;52(3):e12585. doi: 10.1111/cpr.12585. Epub 2019 Feb 22.
|
| 323 |
Oncogenic STRAP Supports Hepatocellular Carcinoma Growth by Enhancing Wnt/-Catenin Signaling.Mol Cancer Res. 2019 Feb;17(2):521-531. doi: 10.1158/1541-7786.MCR-18-0054. Epub 2018 Sep 26.
|
| 324 |
Transgelins, cytoskeletal proteins implicated in different aspects of cancer development.Expert Rev Proteomics. 2014 Apr;11(2):149-65. doi: 10.1586/14789450.2014.860358. Epub 2014 Jan 29.
|
| 325 |
[Expression of Ang2 and Tie2 and their relation with the angiogenesis of hepatocellular carcinoma in rats].Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006 Aug;31(4):523-7.
|
| 326 |
Telomerase reverse transcriptase suppression inhibits cell proliferation and promotes cell apoptosis in hepatocellular cancer.IUBMB Life. 2018 Jul;70(7):642-648. doi: 10.1002/iub.1758. Epub 2018 Apr 29.
|
| 327 |
Expression of iron regulatory genes in a rat model of hepatocellular carcinoma.Liver Int. 2006 Oct;26(8):976-85. doi: 10.1111/j.1478-3231.2006.01316.x.
|
| 328 |
Generation of liver-specific TGF- and c-Myc-overexpressing fibroblasts for future creation of a liver cancer porcine model.Mol Med Rep. 2014 Jul;10(1):329-35. doi: 10.3892/mmr.2014.2217. Epub 2014 May 7.
|
| 329 |
Expressions of transforming growth factor (TGF)-beta1 and TGF-beta type II receptor and their relationship with apoptosis during chemical hepatocarcinogenesis in rats.Hepatol Res. 2003 Nov;27(3):205-213. doi: 10.1016/s1386-6346(03)00264-x.
|
| 330 |
Experimental and bioinformatics comparison of gene expression between T cells from TIL of liver cancer and T cells from UniGene.J Gastroenterol. 2002;37(4):275-82. doi: 10.1007/s005350200035.
|
| 331 |
Thymosin 4 expression in human tissues and in tumors using tissue microarrays.Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):160-7. doi: 10.1097/PAI.0b013e3181f12237.
|
| 332 |
Extracts of Qizhu decoction inhibit hepatitis and hepatocellular carcinoma in vitro and in C57BL/6 mice by suppressing NF-B signaling.Sci Rep. 2019 Feb 5;9(1):1415. doi: 10.1038/s41598-018-38391-9.
|
| 333 |
Betulinic acid promotes TRAIL function on liver cancer progression inhibition through p53/Caspase-3 signaling activation.Biomed Pharmacother. 2017 Apr;88:349-358. doi: 10.1016/j.biopha.2017.01.034. Epub 2017 Jan 21.
|
| 334 |
Luteolin sensitizes human liver cancer cells to TRAILinduced apoptosis via autophagy and JNKmediated death receptor 5 upregulation.Int J Oncol. 2019 Feb;54(2):665-672. doi: 10.3892/ijo.2018.4633. Epub 2018 Nov 14.
|
| 335 |
Suppression of miR-21-3p enhances TRAIL-mediated apoptosis in liver cancer stem cells by suppressing the PI3K/Akt/Bad cascade via regulating PTEN.Cancer Manag Res. 2019 Jan 22;11:955-968. doi: 10.2147/CMAR.S183328. eCollection 2019.
|
| 336 |
Tankyrase Promotes Aerobic Glycolysis and Proliferation of Ovarian Cancer through Activation of Wnt/-Catenin Signaling.Biomed Res Int. 2019 Feb 20;2019:2686340. doi: 10.1155/2019/2686340. eCollection 2019.
|
| 337 |
Prognostic role of targeting protein for Xklp2 in solid tumors: A PRISMA-compliant systematic review and meta-analysis.Medicine (Baltimore). 2018 Oct;97(43):e13018. doi: 10.1097/MD.0000000000013018.
|
| 338 |
Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.Hepatology. 2019 Jul;70(1):198-214. doi: 10.1002/hep.30593. Epub 2019 Apr 12.
|
| 339 |
Functional characterization of Trip10 in cancer cell growth and survival. J Biomed Sci. 2011 Feb 7;18:12.
|
| 340 |
TXNIP overexpression suppresses proliferation and induces apoptosis in SMMC7221 cells through ROS generation and MAPK pathway activation.Oncol Rep. 2017 Jun;37(6):3369-3376. doi: 10.3892/or.2017.5577. Epub 2017 Apr 18.
|
| 341 |
Stabilization of E2-EPF UCP protein is implicated in hepatitis B virus-associated hepatocellular carcinoma progression.Cell Mol Life Sci. 2019 Jul;76(13):2647-2662. doi: 10.1007/s00018-019-03066-9. Epub 2019 Mar 22.
|
| 342 |
Investigation of PD-1H in DEN-induced mouse liver cancer model.Eur Rev Med Pharmacol Sci. 2018 Aug;22(16):5194-5199. doi: 10.26355/eurrev_201808_15716.
|
| 343 |
Inhibition of WWP2 suppresses proliferation, and induces G1 cell cycle arrest and apoptosis in liver cancer cells.Mol Med Rep. 2016 Mar;13(3):2261-6. doi: 10.3892/mmr.2016.4771. Epub 2016 Jan 13.
|
| 344 |
Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas.FEBS Lett. 1975 Nov 15;59(2):245-9. doi: 10.1016/0014-5793(75)80385-1.
|
| 345 |
Slow accumulation of mutations in Xpc-/- mice upon induction of oxidative stress.DNA Repair (Amst). 2013 Dec;12(12):1081-6. doi: 10.1016/j.dnarep.2013.08.019. Epub 2013 Sep 29.
|
| 346 |
CRISPR-Cas9 Screening of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Cells Identifies XPO1 as a Vulnerable Target of Cancer Cells.mBio. 2019 May 14;10(3):e00866-19. doi: 10.1128/mBio.00866-19.
|
| 347 |
Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability.Proc Natl Acad Sci U S A. 2017 May 2;114(18):4691-4696. doi: 10.1073/pnas.1620306114. Epub 2017 Apr 17.
|
| 348 |
Identification and characterization of a novel human hepatocellular carcinoma-associated gene.Br J Cancer. 2001 Oct 19;85(8):1162-7. doi: 10.1054/bjoc.2001.2059.
|
| 349 |
HIF-1 regulates A2B adenosine receptor expression in liver cancer cells.Exp Ther Med. 2019 Dec;18(6):4231-4240. doi: 10.3892/etm.2019.8081. Epub 2019 Oct 7.
|
| 350 |
Aberrant expression of CD13 and stem cell markers in CD133-induced liver cancer in mice.J BUON. 2019 Jul-Aug;24(4):1408-1413.
|
| 351 |
ATP7B Binds Ruthenium(II) p-Cymene Half-Sandwich Complexes: Role of Steric Hindrance and Ru-I Coordination in Rescuing the Sequestration.Inorg Chem. 2019 Nov 18;58(22):15659-15670. doi: 10.1021/acs.inorgchem.9b02780. Epub 2019 Oct 28.
|
| 352 |
Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.JAMA Surg. 2018 Jul 18;153(7):e180996. doi: 10.1001/jamasurg.2018.0996. Epub 2018 Jul 18.
|
| 353 |
MicroRNA?24 negatively regulates chloride intracellular channel1 to suppress the migration and invasion of liver cancer cells.Oncol Rep. 2019 Oct;42(4):1380-1390. doi: 10.3892/or.2019.7250. Epub 2019 Jul 25.
|
| 354 |
Folic acid conjugated polymeric drug delivery vehicle for targeted cancer detection in hepatocellular carcinoma.J Biomed Mater Res A. 2019 Nov;107(11):2522-2535. doi: 10.1002/jbm.a.36758. Epub 2019 Aug 2.
|
| 355 |
Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2.Cancer Res. 2014 Sep 1;74(17):4752-61. doi: 10.1158/0008-5472.CAN-13-3531. Epub 2014 Jun 23.
|
| 356 |
The Mutational Features of Aristolochic Acid-Induced Mouse and Human Liver Cancers.Hepatology. 2020 Mar;71(3):929-942. doi: 10.1002/hep.30863. Epub 2019 Nov 6.
|
| 357 |
The Expression of ILT4 in Myeloid Dendritic Cells in Patients with Hepatocellular Carcinoma.Immunol Invest. 2019 Oct;48(7):704-718. doi: 10.1080/08820139.2019.1571507. Epub 2019 May 2.
|
| 358 |
Role and mechanism of circ-PRKCI in hepatocellular carcinoma.World J Gastroenterol. 2019 Apr 28;25(16):1964-1974. doi: 10.3748/wjg.v25.i16.1964.
|
| 359 |
Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.BMC Genomics. 2015 Feb 25;16(1):124. doi: 10.1186/s12864-015-1312-z.
|
| 360 |
RA-XII Suppresses the Development and Growth of Liver Cancer by Inhibition of Lipogenesis via SCAP-dependent SREBP Supression.Molecules. 2019 May 12;24(9):1829. doi: 10.3390/molecules24091829.
|
| 361 |
Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids via the ATP-AMPK-mTOR-SREBP1 signaling pathway.FASEB J. 2019 Sep;33(9):10089-10103. doi: 10.1096/fj.201802619RR. Epub 2019 Jun 14.
|
| 362 |
Association of TM6SF2 rs58542926 T/C gene polymorphism with hepatocellular carcinoma: a meta-analysis.BMC Cancer. 2019 Nov 21;19(1):1128. doi: 10.1186/s12885-019-6173-4.
|
| 363 |
Expression of TMBIM6 in Cancers: The Involvement of Sp1 and PKC.Cancers (Basel). 2019 Jul 11;11(7):974. doi: 10.3390/cancers11070974.
|
| 364 |
The 2-oxoglutarate carrier promotes liver cancer by sustaining mitochondrial GSH despite cholesterol loading.Redox Biol. 2018 Apr;14:164-177. doi: 10.1016/j.redox.2017.08.022. Epub 2017 Sep 14.
|
| 365 |
The analysis of organic anion transporting polypeptide (OATP) mRNA and protein patterns in primary and metastatic liver cancer.Cancer Biol Ther. 2011 May 1;11(9):801-11. doi: 10.4161/cbt.11.9.15176. Epub 2011 May 1.
|
| 366 |
Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance.Gastroenterology. 2011 Jan;140(1):344-55. doi: 10.1053/j.gastro.2010.07.049. Epub 2010 Aug 2.
|
| 367 |
Novel mechanism of aberrant ZIP4 expression with zinc supplementation in oral tumorigenesis.Biochem Biophys Res Commun. 2017 Jan 29;483(1):339-345. doi: 10.1016/j.bbrc.2016.12.142. Epub 2016 Dec 23.
|
| 368 |
Enhanced antitumor activity of gemcitabine by polysaccharide-induced NK cell activation and immune cytotoxicity reduction in vitro/vivo.Carbohydr Polym. 2017 Oct 1;173:360-371. doi: 10.1016/j.carbpol.2017.06.024. Epub 2017 Jun 10.
|
| 369 |
Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.Lancet HIV. 2018 Nov;5(11):e647-e655. doi: 10.1016/S2352-3018(18)30179-6. Epub 2018 Sep 21.
|
| 370 |
Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma.Oncogene. 2018 Mar;37(12):1637-1653. doi: 10.1038/s41388-017-0070-6. Epub 2018 Jan 16.
|
| 371 |
LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma.Oncotarget. 2017 May 29;8(58):97835-97850. doi: 10.18632/oncotarget.18279. eCollection 2017 Nov 17.
|
| 372 |
Genetic variation of Aflatoxin B1 aldehyde reductase genes (AFAR) in human tumour cells.Cancer Lett. 2008 Dec 8;272(1):160-6. doi: 10.1016/j.canlet.2008.07.013. Epub 2008 Aug 26.
|
| 373 |
Carboxypeptidase A4 promotes proliferation and stem cell characteristics of hepatocellular carcinoma.Int J Exp Pathol. 2019 Apr;100(2):133-138. doi: 10.1111/iep.12315. Epub 2019 May 6.
|
| 374 |
Dopamine-induced SULT1A3/4 promotes EMT and cancer stemness in hepatocellular carcinoma.Tumour Biol. 2017 Oct;39(10):1010428317719272. doi: 10.1177/1010428317719272.
|
| 375 |
Impaired phosphorylation and ubiquitination by p70 S6 kinase (p70S6K) and Smad ubiquitination regulatory factor 1 (Smurf1) promote tribbles homolog 2 (TRIB2) stability and carcinogenic property in liver cancer.J Biol Chem. 2013 Nov 22;288(47):33667-33681. doi: 10.1074/jbc.M113.503292. Epub 2013 Oct 2.
|
| 376 |
ACSS2 promotes systemic fat storage and utilization through selective regulation of genes involved in lipid metabolism.Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9499-E9506. doi: 10.1073/pnas.1806635115. Epub 2018 Sep 18.
|
| 377 |
Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol-associated cancer in heavy drinkers.Int J Cancer. 2006 Apr 15;118(8):1998-2002. doi: 10.1002/ijc.21583.
|
| 378 |
AKR1B10 (Aldo-keto reductase family 1 B10) promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model.Acta Biomater. 2019 Jun;91:195-208. doi: 10.1016/j.actbio.2019.04.053. Epub 2019 Apr 26.
|
| 379 |
Targeting AMP-activated kinase impacts hepatocellular cancer stem cells induced by long-term treatment with sorafenib.Mol Oncol. 2019 May;13(5):1311-1331. doi: 10.1002/1878-0261.12488. Epub 2019 Apr 15.
|
| 380 |
The landscape of cancer cell line metabolism.Nat Med. 2019 May;25(5):850-860. doi: 10.1038/s41591-019-0404-8. Epub 2019 May 8.
|
| 381 |
DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival.J Biol Chem. 2011 Sep 2;286(35):30706-30713. doi: 10.1074/jbc.M111.229831. Epub 2011 Jul 7.
|
| 382 |
25-OH-vitamin D deficiency identifies poor tumor response in hepatocellular carcinoma treated with transarterial chemoembolization.Clin Transl Oncol. 2020 Jan;22(1):70-80. doi: 10.1007/s12094-019-02146-3. Epub 2019 Jun 10.
|
| 383 |
Decrease of hepatic stellate cells in rats with enhanced sensitivity to clofibrate-induced hepatocarcinogenesis. Cancer Sci. 2011 Apr;102(4):735-41. doi: 10.1111/j.1349-7006.2011.01856.x. Epub 2011 Feb 10.
|
| 384 |
Effect of N-acetyltransferase 2 polymorphism on tumor target tissue DNA adduct levels in rapid and slow acetylator congenic rats administered 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine or 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline.Drug Metab Dispos. 2009 Nov;37(11):2123-6. doi: 10.1124/dmd.109.029512. Epub 2009 Aug 10.
|
| 385 |
Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.Oncogene. 2017 Dec 14;36(50):6895-6905. doi: 10.1038/onc.2017.291. Epub 2017 Aug 28.
|
| 386 |
Proliferation-linked increase in phosphoribosylformylglycinamidine synthetase activity (EC 6.3.5.3).Cancer Res. 1984 Jun;44(6):2430-4.
|
| 387 |
A comparison of transcriptomic and metabonomic technologies for identifying biomarkers predictive of two-year rodent cancer bioassays.Toxicol Sci. 2007 Mar;96(1):40-6. doi: 10.1093/toxsci/kfl171. Epub 2006 Nov 17.
|
| 388 |
Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene.Gastroenterology. 2001 Nov;121(5):1136-44. doi: 10.1053/gast.2001.28655.
|
| 389 |
Regulation of UDP-Glucuronosyltransferases UGT2B4 and UGT2B7 by MicroRNAs in Liver Cancer Cells.J Pharmacol Exp Ther. 2017 Jun;361(3):386-397. doi: 10.1124/jpet.116.239707. Epub 2017 Apr 7.
|
| 390 |
The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against sorafenib-tolerant persister cancer cells.Onco Targets Ther. 2019 Jul 8;12:5359-5373. doi: 10.2147/OTT.S212465. eCollection 2019.
|
| 391 |
MAT2B mediates invasion and metastasis by regulating EGFR signaling pathway in hepatocellular carcinoma.Clin Exp Med. 2019 Nov;19(4):535-546. doi: 10.1007/s10238-019-00579-2. Epub 2019 Sep 6.
|
| 392 |
Point-of-Care Assay of Alkaline Phosphatase Enzymatic Activity Using a Thermometer or Temperature Discoloration Sticker as Readout.Anal Chem. 2019 Jun 18;91(12):7943-7949. doi: 10.1021/acs.analchem.9b01883. Epub 2019 May 31.
|
| 393 |
HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression.Cell Rep. 2014 Sep 25;8(6):1930-1942. doi: 10.1016/j.celrep.2014.08.028. Epub 2014 Sep 18.
|
| 394 |
Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.Cell Physiol Biochem. 2017;41(6):2289-2306. doi: 10.1159/000475648. Epub 2017 Apr 26.
|
| 395 |
OY-TES-1 may regulate the malignant behavior of liver cancer via NANOG, CD9, CCND2 and CDCA3: a bioinformatic analysis combine with RNAi and oligonucleotide microarray.Oncol Rep. 2015 Apr;33(4):1965-75. doi: 10.3892/or.2015.3792. Epub 2015 Feb 10.
|
| 396 |
MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.Biochem Biophys Res Commun. 2014 Feb 7;444(2):270-5. doi: 10.1016/j.bbrc.2014.01.051. Epub 2014 Jan 22.
|
| 397 |
Integrative transcriptome analysis of liver cancer profiles identifies upstream regulators and clinical significance of ACSM3 gene expression.Cell Oncol (Dordr). 2017 Jun;40(3):219-233. doi: 10.1007/s13402-017-0321-0. Epub 2017 Apr 7.
|
| 398 |
ARP3 promotes tumor metastasis and predicts a poor prognosis in hepatocellular carcinoma.Pathol Res Pract. 2018 Sep;214(9):1356-1361. doi: 10.1016/j.prp.2018.05.028. Epub 2018 Jun 7.
|
| 399 |
XB130 Knockdown Inhibits the Proliferation, Invasiveness, and Metastasis of Hepatocellular Carcinoma Cells and Sensitizes them to TRAIL-Induced Apoptosis.Chin Med J (Engl). 2018 Oct 5;131(19):2320-2331. doi: 10.4103/0366-6999.241800.
|
| 400 |
Protective effect of RIP and c-FLIP in preventing liver cancer cell apoptosis induced by TRAIL.Int J Clin Exp Pathol. 2015 Jun 1;8(6):6519-25. eCollection 2015.
|
| 401 |
Distinctive pattern of AHNAK methylation level in peripheral blood mononuclear cells and the association with HBV-related liver diseases.Cancer Med. 2018 Oct;7(10):5178-5186. doi: 10.1002/cam4.1778. Epub 2018 Sep 27.
|
| 402 |
A-kinase anchoring protein 12 is downregulated in human hepatocellular carcinoma and its deficiency in mice aggravates thioacetamide-induced liver injury.Oncol Lett. 2018 Nov;16(5):5907-5915. doi: 10.3892/ol.2018.9396. Epub 2018 Sep 4.
|
| 403 |
Design Graph Theoretical Analysis and In Silico Modeling of Dunaliella Bardawil Biomass Encapsulated N-Succinyl Chitosan Nanoparticles for Enhanced Anticancer Activity.Anticancer Agents Med Chem. 2018;18(13):1900-1918. doi: 10.2174/1871520618666180628155223.
|
| 404 |
Metabolic control of PPAR activity by aldehyde dehydrogenase regulates invasive cell behavior and predicts survival in hepatocellular and renal clear cell carcinoma.BMC Cancer. 2018 Nov 28;18(1):1180. doi: 10.1186/s12885-018-5061-7.
|
| 405 |
Label-free cytosensing of cancer cells based on the interaction between protein and an electron-transfer carbohydrate-mimetic peptide.Anal Chim Acta. 2018 Dec 21;1040:166-176. doi: 10.1016/j.aca.2018.08.025. Epub 2018 Aug 16.
|
| 406 |
Reciprocal regulation between TrCP and Smurf1 suppresses proliferative capacity of liver cancer cells.J Cell Physiol. 2017 Dec;232(12):3347-3359. doi: 10.1002/jcp.25780. Epub 2017 Mar 6.
|
| 407 |
Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma.Nat Commun. 2018 Feb 14;9(1):678. doi: 10.1038/s41467-018-03024-2.
|
| 408 |
Targeting CAND1 promotes caspase-8/RIP1-dependent apoptosis in liver cancer cells.Am J Transl Res. 2018 May 15;10(5):1357-1372. eCollection 2018.
|
| 409 |
miR-449a promotes liver cancer cell apoptosis by downregulation of Calpain 6 and POU2F1.Oncotarget. 2016 Mar 22;7(12):13491-501. doi: 10.18632/oncotarget.4821.
|
| 410 |
HMDB and 5-AzadC Combination Reverses Tumor Suppressor CCAAT/Enhancer-Binding Protein Delta to Strengthen the Death of Liver Cancer Cells.Mol Cancer Ther. 2015 Nov;14(11):2623-33. doi: 10.1158/1535-7163.MCT-15-0025. Epub 2015 Sep 10.
|
| 411 |
Ceramide synthase-4 orchestrates the cell proliferation and tumor growth of liver cancer in vitro and in vivo through the nuclear factor-B signaling pathway.Oncol Lett. 2017 Aug;14(2):1477-1483. doi: 10.3892/ol.2017.6365. Epub 2017 Jun 9.
|
| 412 |
Inducible factors for cancer-associated fibroblasts in liver cancer versus myofibroblasts in inflammatory liver disease.Histol Histopathol. 2016 Feb;31(2):141-8. doi: 10.14670/HH-11-668. Epub 2015 Sep 23.
|
| 413 |
Cyclic adenosine monophosphate response element-binding protein transcriptionally regulates CHCHD2 associated with the molecular pathogenesis of hepatocellular carcinoma.Mol Med Rep. 2015 Jun;11(6):4053-62. doi: 10.3892/mmr.2015.3256. Epub 2015 Jan 26.
|
| 414 |
CISD2 associated with proliferation indicates negative prognosis in patients with hepatocellular carcinoma.Int J Clin Exp Pathol. 2015 Oct 1;8(10):13725-38. eCollection 2015.
|
| 415 |
CLDN3 inhibits cancer aggressiveness via Wnt-EMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma.Oncotarget. 2014 Sep 15;5(17):7663-76. doi: 10.18632/oncotarget.2288.
|
| 416 |
Dectin-1 Regulates Hepatic Fibrosis and Hepatocarcinogenesis by Suppressing TLR4 Signaling Pathways.Cell Rep. 2015 Dec 1;13(9):1909-1921. doi: 10.1016/j.celrep.2015.10.058. Epub 2015 Nov 19.
|
| 417 |
SiRNA-Mediated Down-Regulation of CLIC4 Gene Inhibits Cell Proliferation and Accelerates Cell Apoptosis of Mouse Liver Cancer Hca-F and Hca-P Cells.J Cell Biochem. 2018 Jan;119(1):659-668. doi: 10.1002/jcb.26229. Epub 2017 Jul 31.
|
| 418 |
High GSTP1 inhibits cell proliferation by reducing Akt phosphorylation and is associated with a better prognosis in hepatocellular carcinoma.Oncotarget. 2017 Dec 19;9(10):8957-8971. doi: 10.18632/oncotarget.23420. eCollection 2018 Feb 6.
|
| 419 |
DDX3, a potential target for cancer treatment.Mol Cancer. 2015 Nov 5;14:188. doi: 10.1186/s12943-015-0461-7.
|
| 420 |
-defensin 1 expression in HCV infected liver/liver cancer: an important role in protecting HCV progression and liver cancer development.Sci Rep. 2017 Oct 17;7(1):13404. doi: 10.1038/s41598-017-13332-0.
|
| 421 |
DEPDC7 inhibits cell proliferation, migration and invasion in hepatoma cells.Oncol Lett. 2017 Dec;14(6):7332-7338. doi: 10.3892/ol.2017.7128. Epub 2017 Oct 3.
|
| 422 |
Establishment of a novel hepatic steatosis cell model by Cas9/sgRNA-mediated DGK gene knockout.Mol Med Rep. 2018 Feb;17(2):2169-2176. doi: 10.3892/mmr.2017.8140. Epub 2017 Nov 22.
|
| 423 |
Plasma glutamate carboxypeptidase is a negative regulator in liver cancer metastasis.Oncotarget. 2016 Nov 29;7(48):79774-79786. doi: 10.18632/oncotarget.12967.
|
| 424 |
Hepatitis B core protein promotes liver cancer metastasis through miR-382-5p/DLC-1 axis.Biochim Biophys Acta Mol Cell Res. 2018 Jan;1865(1):1-11. doi: 10.1016/j.bbamcr.2017.09.020. Epub 2017 Oct 3.
|
| 425 |
MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis.J Exp Clin Cancer Res. 2018 Oct 16;37(1):252. doi: 10.1186/s13046-018-0927-8.
|
| 426 |
Attenuation of enoyl coenzyme A hydratase 1 expression in colorectal cancer cells using small interfering RNA inhibits cell proliferation and migration.Mol Med Rep. 2015 Jul;12(1):470-4. doi: 10.3892/mmr.2015.3418. Epub 2015 Mar 4.
|
| 427 |
High EIF2B5 mRNA expression and its prognostic significance in liver cancer: a study based on the TCGA and GEO database.Cancer Manag Res. 2018 Nov 20;10:6003-6014. doi: 10.2147/CMAR.S185459. eCollection 2018.
|
| 428 |
miRNA-346 promotes proliferation, migration and invasion in liver cancer.Oncol Lett. 2017 Sep;14(3):3255-3260. doi: 10.3892/ol.2017.6561. Epub 2017 Jul 8.
|
| 429 |
Genetic risk analysis for an individual according to the theory of programmed onset, illustrated by lung and liver cancers.Gene. 2018 Oct 5;673:107-111. doi: 10.1016/j.gene.2018.06.044. Epub 2018 Jun 15.
|
| 430 |
NS5ABP37 inhibits liver cancer by impeding lipogenesis and cholesterogenesis.Cancer Sci. 2017 Jan;108(1):12-22. doi: 10.1111/cas.13117.
|
| 431 |
Follistatin-like protein 5 inhibits hepatocellular carcinoma progression by inducing caspase-dependent apoptosis and regulating Bcl-2 family proteins.J Cell Mol Med. 2018 Dec;22(12):6190-6201. doi: 10.1111/jcmm.13906. Epub 2018 Sep 25.
|
| 432 |
GALNT14 genotype effectively predicts the therapeutic response in unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization.Pharmacogenomics. 2016 Mar;17(4):353-66. doi: 10.2217/pgs.15.179. Epub 2016 Feb 12.
|
| 433 |
LncGPR107 drives the self-renewal of liver tumor initiating cells and liver tumorigenesis through GPR107-dependent manner.J Exp Clin Cancer Res. 2018 Jun 20;37(1):121. doi: 10.1186/s13046-018-0794-3.
|
| 434 |
Loss of NR2E3 represses AHR by LSD1 reprogramming, is associated with poor prognosis in liver cancer.Sci Rep. 2017 Sep 6;7(1):10662. doi: 10.1038/s41598-017-11106-2.
|
| 435 |
H2A.Z regulates tumorigenesis, metastasis and sensitivity to cisplatin in intrahepatic cholangiocarcinoma.Int J Oncol. 2018 Apr;52(4):1235-1245. doi: 10.3892/ijo.2018.4292. Epub 2018 Feb 28.
|
| 436 |
Comprehensive molecular profiling of the B7 family in gastrointestinal cancer.Cell Prolif. 2018 Oct;51(5):e12468. doi: 10.1111/cpr.12468. Epub 2018 Jul 12.
|
| 437 |
Suppression of Lefty expression in induced pluripotent cancer cells.FASEB J. 2013 Jun;27(6):2165-74. doi: 10.1096/fj.12-221432. Epub 2013 Feb 13.
|
| 438 |
Homeobox containing1 inhibits liver cancer progression by promoting autophagy as well as inhibiting stemness and immune escape.Oncol Rep. 2018 Sep;40(3):1657-1665. doi: 10.3892/or.2018.6551. Epub 2018 Jul 10.
|
| 439 |
Abnormal expression of HMGB-3 is significantly associated with malignant transformation of hepatocytes.World J Gastroenterol. 2018 Aug 28;24(32):3650-3662. doi: 10.3748/wjg.v24.i32.3650.
|
| 440 |
LncHOXA10 drives liver TICs self-renewal and tumorigenesis via HOXA10 transcription activation.Mol Cancer. 2018 Dec 13;17(1):173. doi: 10.1186/s12943-018-0921-y.
|
| 441 |
Fenretinide inhibits the proliferation and migration of human liver cancer HepG2 cells by downregulating the activation of myosin light chain kinase through the p38MAPK signaling pathway.Oncol Rep. 2018 Jul;40(1):518-526. doi: 10.3892/or.2018.6436. Epub 2018 May 16.
|
| 442 |
Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype.Carcinogenesis. 2013 Jul;34(7):1543-50. doi: 10.1093/carcin/bgt095. Epub 2013 Mar 18.
|
| 443 |
Transcriptional regulation of IER5 in response to radiation in HepG2.Cancer Gene Ther. 2016 Feb-Mar;23(2-3):61-5. doi: 10.1038/cgt.2016.1. Epub 2016 Feb 26.
|
| 444 |
Vitamin K(2) supplementation blocks the beneficial effects of IFN--2b administered on the early stages of liver cancer development in rats.Nutrition. 2019 Mar;59:170-179. doi: 10.1016/j.nut.2018.08.016. Epub 2018 Aug 25.
|
| 445 |
Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma.Hepatology. 2014 May;59(5):1900-11. doi: 10.1002/hep.26997. Epub 2014 Apr 1.
|
| 446 |
JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.Cancer Res. 2017 Oct 1;77(19):5287-5300. doi: 10.1158/0008-5472.CAN-17-0229. Epub 2017 Aug 3.
|
| 447 |
Suppressed Krppellike factor 17 expression induces tumor proliferation, metastasis and a poor prognosis in papillary thyroid carcinoma.Mol Med Rep. 2014 Oct;10(4):2087-92. doi: 10.3892/mmr.2014.2429. Epub 2014 Jul 29.
|
| 448 |
Galactose Derivative-Modified Nanoparticles for Efficient siRNA Delivery to Hepatocellular Carcinoma.Biomacromolecules. 2018 Jun 11;19(6):2330-2339. doi: 10.1021/acs.biomac.8b00358. Epub 2018 May 29.
|
| 449 |
Transforming growth factor-beta1 suppresses hepatocellular carcinoma proliferation via activation of Hippo signaling.Oncotarget. 2017 May 2;8(18):29785-29794. doi: 10.18632/oncotarget.14523.
|
| 450 |
microRNA-22 downregulation of galectin-9 influences lymphocyte apoptosis and tumor cell proliferation in liver cancer.Oncol Rep. 2015 Oct;34(4):1771-8. doi: 10.3892/or.2015.4167. Epub 2015 Jul 31.
|
| 451 |
Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.Gastroenterology. 2018 Aug;155(2):557-571.e14. doi: 10.1053/j.gastro.2018.04.032. Epub 2018 May 5.
|
| 452 |
LncMAPK6 drives MAPK6 expression and liver TIC self-renewal.J Exp Clin Cancer Res. 2018 May 15;37(1):105. doi: 10.1186/s13046-018-0770-y.
|
| 453 |
Targeted expression of BikDD combined with metronomic doxorubicin induces synergistic antitumor effect through Bax activation in hepatocellular carcinoma.Oncotarget. 2015 Sep 15;6(27):23807-19. doi: 10.18632/oncotarget.4278.
|
| 454 |
Increased mediator complex subunit 15 expression is associated with poor prognosis in hepatocellular carcinoma.Oncol Lett. 2018 Apr;15(4):4303-4313. doi: 10.3892/ol.2018.7820. Epub 2018 Jan 18.
|
| 455 |
NASP antagonize chromatin accessibility through maintaining histone H3K9me1 in hepatocellular carcinoma.Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3438-3448. doi: 10.1016/j.bbadis.2018.07.033. Epub 2018 Aug 1.
|
| 456 |
Imbalanced expression pattern of steroid receptor coactivator-1 and -3 in liver cancer compared with normal liver: An immunohistochemical study with tissue microarray.Oncol Lett. 2018 Nov;16(5):6339-6348. doi: 10.3892/ol.2018.9443. Epub 2018 Sep 17.
|
| 457 |
Hepatocellular Carcinoma Outcome Is Predicted by Expression of Neuronal Calcium Sensor 1.Cancer Epidemiol Biomarkers Prev. 2018 Sep;27(9):1091-1100. doi: 10.1158/1055-9965.EPI-18-0167. Epub 2018 May 22.
|
| 458 |
Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer.Mol Cancer Res. 2018 Nov;16(11):1713-1723. doi: 10.1158/1541-7786.MCR-18-0313. Epub 2018 Aug 6.
|
| 459 |
NKD1 marks intestinal and liver tumors linked to aberrant Wnt signaling.Cell Signal. 2015 Feb;27(2):245-56. doi: 10.1016/j.cellsig.2014.11.008. Epub 2014 Nov 14.
|
| 460 |
Methylation of nucleolar and coiled-body phosphoprotein1 is associated with the mechanism of tumorigenesis in hepatocellular carcinoma.Oncol Rep. 2013 Nov;30(5):2220-8. doi: 10.3892/or.2013.2676. Epub 2013 Aug 20.
|
| 461 |
NUMB phosphorylation destabilizes p53 and promotes self-renewal of tumor-initiating cells by a NANOG-dependent mechanism in liver cancer.Hepatology. 2015 Nov;62(5):1466-79. doi: 10.1002/hep.27987. Epub 2015 Aug 28.
|
| 462 |
Transcriptome Analysis Uncovers a Growth-Promoting Activity of Orosomucoid-1 on Hepatocytes.EBioMedicine. 2017 Oct;24:257-266. doi: 10.1016/j.ebiom.2017.09.008. Epub 2017 Sep 12.
|
| 463 |
NOR1 promotes hepatocellular carcinoma cell proliferation and migration through modulating the Notch signaling pathway.Exp Cell Res. 2017 Mar 15;352(2):375-381. doi: 10.1016/j.yexcr.2017.02.032. Epub 2017 Feb 21.
|
| 464 |
Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis.Hepatology. 2017 Feb;65(2):515-528. doi: 10.1002/hep.28887. Epub 2016 Nov 29.
|
| 465 |
Silencing HIWI suppresses the growth, invasion and migration of glioma cells.Int J Oncol. 2014 Dec;45(6):2385-92. doi: 10.3892/ijo.2014.2673. Epub 2014 Sep 25.
|
| 466 |
Plectin deficiency in liver cancer cells promotes cell migration and sensitivity to sorafenib treatment.Cell Adh Migr. 2018 Jan 2;12(1):19-27. doi: 10.1080/19336918.2017.1288789. Epub 2017 Feb 17.
|
| 467 |
Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair.Cell. 2016 Jan 28;164(3):538-49. doi: 10.1016/j.cell.2015.12.050. Epub 2016 Jan 21.
|
| 468 |
Chitosan-coated doxorubicin nano-particles drug delivery system inhibits cell growth of liver cancer via p53/PRC1 pathway.Biochem Biophys Res Commun. 2018 Jan 1;495(1):414-420. doi: 10.1016/j.bbrc.2017.10.156. Epub 2017 Oct 31.
|
| 469 |
Aberrant expression of peroxiredoxin 1 and its clinical implications in liver cancer.World J Gastroenterol. 2015 Oct 14;21(38):10840-52. doi: 10.3748/wjg.v21.i38.10840.
|
| 470 |
The effect of CXCL9 on the invasion ability of hepatocellular carcinoma through up-regulation of PREX2.J Mol Histol. 2014 Dec;45(6):689-96. doi: 10.1007/s10735-014-9593-0. Epub 2014 Aug 24.
|
| 471 |
The role of PRRX1 in the apoptosis of A549 cells induced by cisplatin.Am J Transl Res. 2017 Feb 15;9(2):396-402. eCollection 2017.
|
| 472 |
POH1 deubiquitylates and stabilizes E2F1 to promote tumour formation.Nat Commun. 2015 Oct 29;6:8704. doi: 10.1038/ncomms9704.
|
| 473 |
Mice lacking RAP1 show early onset and higher rates of DEN-induced hepatocellular carcinomas in female mice.PLoS One. 2018 Oct 11;13(10):e0204909. doi: 10.1371/journal.pone.0204909. eCollection 2018.
|
| 474 |
Inhibition of RAD54B suppresses proliferation and promotes apoptosis in hepatoma cells.Oncol Rep. 2018 Sep;40(3):1233-1242. doi: 10.3892/or.2018.6522. Epub 2018 Jun 25.
|
| 475 |
RAMP3 is a prognostic indicator of liver cancer and might reduce the adverse effect of TP53 mutation on survival.Future Oncol. 2018 Oct;14(25):2615-2625. doi: 10.2217/fon-2018-0296. Epub 2018 Jun 8.
|
| 476 |
The caspase-3/p120 RasGAP stress-sensing module reduces liver cancer incidence but does not affect overall survival in gamma-irradiated and carcinogen-treated mice.Mol Carcinog. 2017 Jun;56(6):1680-1684. doi: 10.1002/mc.22624. Epub 2017 Feb 16.
|
| 477 |
RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.J Exp Clin Cancer Res. 2018 Sep 3;37(1):212. doi: 10.1186/s13046-018-0852-x.
|
| 478 |
Induction of autophagy and senescence by knockdown of ROC1 E3 ubiquitin ligase to suppress the growth of liver cancer cells.Cell Death Differ. 2013 Feb;20(2):235-47. doi: 10.1038/cdd.2012.113. Epub 2012 Aug 31.
|
| 479 |
Upregulation of RECQL4 expression predicts poor prognosis in hepatocellular carcinoma.Oncol Lett. 2018 Apr;15(4):4248-4254. doi: 10.3892/ol.2018.7860. Epub 2018 Jan 25.
|
| 480 |
Oncogene RPA1 promotes proliferation of hepatocellular carcinoma via CDK4/Cyclin-D pathway.Biochem Biophys Res Commun. 2018 Apr 6;498(3):424-430. doi: 10.1016/j.bbrc.2018.02.167. Epub 2018 Mar 15.
|
| 481 |
R-spondin 2 promotes proliferation and migration via the Wnt/-catenin pathway in human hepatocellular carcinoma.Oncol Lett. 2017 Aug;14(2):1757-1765. doi: 10.3892/ol.2017.6339. Epub 2017 Jun 7.
|
| 482 |
The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma.Cancer Genet Cytogenet. 2007 Aug;177(1):6-15. doi: 10.1016/j.cancergencyto.2007.04.007.
|
| 483 |
Identification of natural splice variants of SAMHD1 in virus-infected HCC.Oncol Rep. 2014 Feb;31(2):687-92. doi: 10.3892/or.2013.2895. Epub 2013 Dec 5.
|
| 484 |
Ultrasensitive Detection of Serum MicroRNA Using Branched DNA-Based SERS Platform Combining Simultaneous Detection of -Fetoprotein for Early Diagnosis of Liver Cancer.ACS Appl Mater Interfaces. 2018 Oct 17;10(41):34869-34877. doi: 10.1021/acsami.8b10252. Epub 2018 Oct 5.
|
| 485 |
Promoter methylation assay of SASH1 gene in hepatocellular carcinoma.J BUON. 2014 Oct-Dec;19(4):1041-7.
|
| 486 |
Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis.J Biol Chem. 2017 Jun 2;292(22):9022-9033. doi: 10.1074/jbc.M117.778001. Epub 2017 Apr 25.
|
| 487 |
SF3B4 as an early-stage diagnostic marker and driver of hepatocellular carcinoma.BMB Rep. 2018 Feb;51(2):57-58. doi: 10.5483/bmbrep.2018.51.2.021.
|
| 488 |
Facilitation of liver cancer SMCC7721 cell aging by sirtuin 4 via inhibiting JAK2/STAT3 signal pathway.Eur Rev Med Pharmacol Sci. 2017 Mar;21(6):1248-1253.
|
| 489 |
SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinoma.RNA Biol. 2018;15(10):1364-1375. doi: 10.1080/15476286.2018.1534525. Epub 2018 Oct 25.
|
| 490 |
RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.Hepatology. 2018 Jun;67(6):2254-2270. doi: 10.1002/hep.29683. Epub 2018 Apr 19.
|
| 491 |
Cisplatin-induced downregulation of SOX1 increases drug resistance by activating autophagy in non-small cell lung cancer cell.Biochem Biophys Res Commun. 2013 Sep 20;439(2):187-90. doi: 10.1016/j.bbrc.2013.08.065. Epub 2013 Aug 29.
|
| 492 |
Speckle-type POZ protein is negatively associated with malignancies and inhibits cell proliferation and migration in liver cancer.Tumour Biol. 2015 Dec;36(12):9753-61. doi: 10.1007/s13277-015-3753-z. Epub 2015 Jul 10.
|
| 493 |
SPRTN protease and checkpoint kinase 1 cross-activation loop safeguards DNA replication.Nat Commun. 2019 Jul 17;10(1):3142. doi: 10.1038/s41467-019-11095-y.
|
| 494 |
[ARTICLE WITHDRAWN] Downregulation of SRC Kinase Signaling Inhibitor 1 (SRCIN1) Expression by MicroRNA-32 Promotes Proliferation and Epithelial-Mesenchymal Transition in Human Liver Cancer Cells.Oncol Res. 2018 May 7;26(4):573-579. doi: 10.3727/096504017X14954923820137. Epub 2017 May 22.
|
| 495 |
Connexin 43 SUMOylation improves gap junction functions between liver cancer stem cells and enhances their sensitivity to HSVtk/GCV.Int J Oncol. 2018 Mar;52(3):872-880. doi: 10.3892/ijo.2018.4263. Epub 2018 Feb 1.
|
| 496 |
The Down-Regulation of SUZ12 Accelerates the Migration and Invasion of Liver Cancer Cells via Activating ERK1/2 Pathway.J Cancer. 2019 Feb 23;10(6):1375-1384. doi: 10.7150/jca.29932. eCollection 2019.
|
| 497 |
Knockdown of TWIST enhances the cytotoxicity of chemotherapeutic drugs in doxorubicin-resistant HepG2 cells by suppressing MDR1 and EMT.Int J Oncol. 2018 Oct;53(4):1763-1773. doi: 10.3892/ijo.2018.4495. Epub 2018 Jul 20.
|
| 498 |
C8orf4 negatively regulates self-renewal of liver cancer stem cells via suppression of NOTCH2 signalling.Nat Commun. 2015 May 19;6:7122. doi: 10.1038/ncomms8122.
|
| 499 |
Tex10 is upregulated and promotes cancer stem cell properties and chemoresistance in hepatocellular carcinoma.Cell Cycle. 2018;17(11):1310-1318. doi: 10.1080/15384101.2018.1480208. Epub 2018 Jul 25.
|
| 500 |
LncRNA DILC participates in rheumatoid arthritis by inducing apoptosis of fibroblast-like synoviocytes and down-regulating IL-6.Biosci Rep. 2019 May 2;39(5):BSR20182374. doi: 10.1042/BSR20182374. Print 2019 May 31.
|
| 501 |
CD133-induced TM4SF5 expression promotes sphere growth via recruitment and blocking of protein tyrosine phosphatase receptor type F (PTPRF).Cancer Lett. 2018 Dec 1;438:219-231. doi: 10.1016/j.canlet.2018.09.009. Epub 2018 Sep 11.
|
| 502 |
MiR-155 targets TP53INP1 to regulate liver cancer stem cell acquisition and self-renewal.FEBS Lett. 2015 Feb 13;589(4):500-6. doi: 10.1016/j.febslet.2015.01.009. Epub 2015 Jan 17.
|
| 503 |
Effect on the liver cancer cell invasion ability by studying the associations between autophagy and TRAP1 expression.Oncol Lett. 2018 Jul;16(1):991-997. doi: 10.3892/ol.2018.8774. Epub 2018 May 22.
|
| 504 |
A Trib2-p38 axis controls myeloid leukaemia cell cycle and stress response signalling.Cell Death Dis. 2018 May 1;9(5):443. doi: 10.1038/s41419-018-0467-3.
|
| 505 |
Overexpression of CMTM7 inhibits cell growth and migration in liver cancer.Kaohsiung J Med Sci. 2019 Jun;35(6):332-340. doi: 10.1002/kjm2.12058. Epub 2019 Mar 23.
|
| 506 |
Dishevelled 1, a pivotal positive regulator of the Wnt signalling pathway, mediates 5-fluorouracil resistance in HepG2 cells.Artif Cells Nanomed Biotechnol. 2018;46(sup2):192-200. doi: 10.1080/21691401.2018.1453827. Epub 2018 Mar 27.
|
| 507 |
Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression.Sci Rep. 2018 Apr 26;8(1):6586. doi: 10.1038/s41598-018-24633-3.
|
| 508 |
The FHL2 regulation in the transcriptional circuitry of human cancers.Gene. 2015 Nov 1;572(1):1-7. doi: 10.1016/j.gene.2015.07.043. Epub 2015 Jul 26.
|
| 509 |
[Exploration of Epigenetic Changes and DNA Methylation Markers Associated with Liver Tumors Induced by Inorganic Arsenite Exposure in Mice].Nihon Eiseigaku Zasshi. 2015;70(3):181-5. doi: 10.1265/jjh.70.181.
|
| 510 |
LncFZD6 initiates Wnt/-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation.Oncogene. 2018 Jun;37(23):3098-3112. doi: 10.1038/s41388-018-0203-6. Epub 2018 Mar 14.
|
| 511 |
GDF11/BMP11 as a novel tumor marker for liver cancer.Exp Ther Med. 2018 Apr;15(4):3495-3500. doi: 10.3892/etm.2018.5861. Epub 2018 Feb 12.
|
| 512 |
Hepatitis B virus upregulates GP73 expression by activating the HIF-2 signaling pathway.Oncol Lett. 2018 Apr;15(4):5264-5270. doi: 10.3892/ol.2018.7955. Epub 2018 Feb 5.
|
| 513 |
GTSF1 gene may serve as a novel potential diagnostic biomarker for liver cancer.Oncol Lett. 2018 Mar;15(3):3133-3140. doi: 10.3892/ol.2017.7695. Epub 2017 Dec 27.
|
| 514 |
The role of kinesin KIF18A in the invasion and metastasis of hepatocellular carcinoma.World J Surg Oncol. 2018 Feb 21;16(1):36. doi: 10.1186/s12957-018-1342-5.
|
| 515 |
MORC2, a novel oncogene, is upregulated in liver cancer and contributes to proliferation, metastasis and chemoresistance.Int J Oncol. 2018 Jul;53(1):59-72. doi: 10.3892/ijo.2018.4333. Epub 2018 Mar 27.
|
| 516 |
Overexpression of RHEB is associated with metastasis and poor prognosis in hepatocellular carcinoma.Oncol Lett. 2018 Mar;15(3):3838-3845. doi: 10.3892/ol.2018.7759. Epub 2018 Jan 10.
|
| 517 |
HIF-1-induced RIT1 promotes liver cancer growth and metastasis and its deficiency increases sensitivity to sorafenib.Cancer Lett. 2019 Sep 28;460:96-107. doi: 10.1016/j.canlet.2019.06.016. Epub 2019 Jun 24.
|
| 518 |
Analysis of long non-coding RNA (lncRNA) expression in hepatitis B patients.Bosn J Basic Med Sci. 2018 May 20;18(2):150-161. doi: 10.17305/bjbms.2018.2800.
|
| 519 |
Sensitive ADAR editing reporter in cancer cells enables high-throughput screening of small molecule libraries.Nucleic Acids Res. 2019 Feb 28;47(4):e22. doi: 10.1093/nar/gky1228.
|
| 520 |
Molecular cloning and characterization of a RING-H2 finger protein, ANAPC11, the human homolog of yeast Apc11p.J Cell Biochem. 2001 Aug 1-9;83(2):249-58. doi: 10.1002/jcb.1217.
|
| 521 |
Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer.Neoplasia. 2009 Feb;11(2):196-206. doi: 10.1593/neo.08734.
|
| 522 |
Argininosuccinate lyase is a potential therapeutic target in breast cancer.Oncol Rep. 2015 Dec;34(6):3131-9. doi: 10.3892/or.2015.4280. Epub 2015 Sep 16.
|
| 523 |
The Munich-Transarterial Chemoembolisation Score Holds Superior Prognostic Capacities Compared to TACE-Tailored Modifications of 9 Established Staging Systems for Hepatocellular Carcinoma.Digestion. 2019;100(1):15-26. doi: 10.1159/000493136. Epub 2018 Oct 3.
|
| 524 |
MicroRNA-550a acts as a pro-metastatic gene and directly targets cytoplasmic polyadenylation element-binding protein 4 in hepatocellular carcinoma.PLoS One. 2012;7(11):e48958. doi: 10.1371/journal.pone.0048958. Epub 2012 Nov 7.
|
| 525 |
Human CRYL1, a novel enzyme-crystallin overexpressed in liver and kidney and downregulated in 58% of liver cancer tissues from 60 Chinese patients, and four new homologs from other mammalians.Gene. 2003 Jan 2;302(1-2):103-13. doi: 10.1016/s0378-1119(02)01095-8.
|
| 526 |
Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis.Hepatology. 2009 Feb;49(2):513-22. doi: 10.1002/hep.22698.
|
| 527 |
ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis.Mol Carcinog. 2009 Feb;48(2):130-40. doi: 10.1002/mc.20461.
|
| 528 |
Serum starvation induces DRAM expression in liver cancer cells via histone modifications within its promoter locus.PLoS One. 2012;7(12):e50502. doi: 10.1371/journal.pone.0050502. Epub 2012 Dec 12.
|
| 529 |
The role of CUGBP1 in age-dependent changes of liver functions.Ageing Res Rev. 2012 Sep;11(4):442-9. doi: 10.1016/j.arr.2012.02.007. Epub 2012 Mar 14.
|
| 530 |
Antisense oligonucleotide Elk-1 suppresses the tumorigenicity of human hepatocellular carcinoma cells.Cell Biol Int. 2008 Feb;32(2):210-6. doi: 10.1016/j.cellbi.2007.08.027. Epub 2007 Sep 7.
|
| 531 |
High FOXK1 expression correlates with poor outcomes in hepatocellular carcinoma and regulates stemness of hepatocellular carcinoma cells.Life Sci. 2019 Jul 1;228:128-134. doi: 10.1016/j.lfs.2019.04.068. Epub 2019 May 1.
|
| 532 |
Far upstream element-binding protein 1 facilitates hepatocellular carcinoma invasion and metastasis.Carcinogenesis. 2020 Jul 14;41(7):950-960. doi: 10.1093/carcin/bgz171.
|
| 533 |
LDB2 inhibits proliferation and migration in liver cancer cells by abrogating HEY1 expression.Oncotarget. 2017 Oct 10;8(55):94440-94449. doi: 10.18632/oncotarget.21772. eCollection 2017 Nov 7.
|
| 534 |
Circulating Lamin B1 (LMNB1) biomarker detects early stages of liver cancer in patients.J Proteome Res. 2010 Jan;9(1):70-8. doi: 10.1021/pr9002118.
|
| 535 |
Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice.Gastroenterology. 2012 Dec;143(6):1660-1669.e7. doi: 10.1053/j.gastro.2012.09.002. Epub 2012 Sep 11.
|
| 536 |
Transforming Growth Factor TGF Increases Levels of Microtubule-Associated Protein MAP1S and Autophagy Flux in Pancreatic Ductal Adenocarcinomas.PLoS One. 2015 Nov 16;10(11):e0143150. doi: 10.1371/journal.pone.0143150. eCollection 2015.
|
| 537 |
Expressions of Carbohydrate Response Element Binding Protein and Glucose Transporters in Liver Cancer and Clinical Significance.Pathol Oncol Res. 2020 Apr;26(2):1331-1340. doi: 10.1007/s12253-019-00708-y. Epub 2019 Aug 12.
|
| 538 |
Phenotypic and functional differences between human liver cancer endothelial cells and liver sinusoidal endothelial cells.J Vasc Res. 2008;45(1):78-86. doi: 10.1159/000109079. Epub 2007 Sep 27.
|
| 539 |
Growth inhibition of hepatocellular carcinoma cells in vitro and in vivo by the 8-methoxy analog of WMC79.Cancer Chemother Pharmacol. 2009 Apr;63(5):769-78. doi: 10.1007/s00280-008-0801-z. Epub 2008 Jul 19.
|
| 540 |
Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma.J Cell Biochem. 2010 Jun 1;110(3):687-96. doi: 10.1002/jcb.22579.
|
| 541 |
Genetic variation in the NBS1 gene is associated with hepatic cancer risk in a Chinese population.DNA Cell Biol. 2012 May;31(5):678-82. doi: 10.1089/dna.2011.1421. Epub 2011 Nov 9.
|
| 542 |
The role of 5' untranslated region in translational suppression of OKL38 mRNA in hepatocellular carcinoma.Oncogene. 2007 Feb 22;26(8):1155-65. doi: 10.1038/sj.onc.1209896. Epub 2006 Aug 21.
|
| 543 |
Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma.Oncotarget. 2017 Jan 10;8(2):3018-3028. doi: 10.18632/oncotarget.13822.
|
| 544 |
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib.Cell Death Dis. 2017 Oct 26;8(10):e3138. doi: 10.1038/cddis.2017.512.
|
| 545 |
Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer.Gastroenterology. 2006 Oct;131(4):1218-27. doi: 10.1053/j.gastro.2006.07.020. Epub 2006 Jul 24.
|
| 546 |
Expression of the prothymosin-a gene as a prognostic factor in lung cancer.Surg Today. 2001;31(10):936-8. doi: 10.1007/s005950170040.
|
| 547 |
Activation of cellular immunity and marked inhibition of liver cancer in a mouse model following gene therapy and tumor expression of GM-SCF, IL-21, and Rae-1.Mol Cancer. 2013 Dec 18;12(1):166. doi: 10.1186/1476-4598-12-166.
|
| 548 |
Ribose-5-phosphate isomerase A overexpression promotes liver cancer development in transgenic zebrafish via activation of ERK and -catenin pathways.Carcinogenesis. 2019 May 14;40(3):461-473. doi: 10.1093/carcin/bgy155.
|
| 549 |
Methylation analysis of p16, SLIT2, SCARA5, and Runx3 genes in hepatocellular carcinoma.Medicine (Baltimore). 2017 Oct;96(41):e8279. doi: 10.1097/MD.0000000000008279.
|
| 550 |
Splicing Regulator p54(nrb) /Non-POU Domain-Containing Octamer-Binding Protein Enhances Carcinogenesis Through Oncogenic Isoform Switch of MYC Box-Dependent Interacting Protein 1 in Hepatocellular Carcinoma.Hepatology. 2020 Aug;72(2):548-568. doi: 10.1002/hep.31062. Epub 2020 Mar 25.
|
| 551 |
Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.Gastroenterology. 2010 May;138(5):1898-908. doi: 10.1053/j.gastro.2009.12.044. Epub 2009 Dec 29.
|
| 552 |
Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells.Med Sci Monit. 2019 Aug 5;25:5823-5832. doi: 10.12659/MSM.915754.
|
| 553 |
SP1 plays a pivotal role for basal activity of TIGAR promoter in liver cancer cell lines.Mol Cell Biochem. 2012 Jan;359(1-2):17-23. doi: 10.1007/s11010-011-0993-0. Epub 2011 Jul 15.
|
| 554 |
The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras.Mol Cell. 2012 Mar 9;45(5):610-8. doi: 10.1016/j.molcel.2012.01.006. Epub 2012 Feb 8.
|
| 555 |
Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer.Chin J Cancer. 2017 Sep 26;36(1):77. doi: 10.1186/s40880-017-0240-5.
|
| 556 |
TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells.BMC Cancer. 2006 Jun 9;6:154. doi: 10.1186/1471-2407-6-154.
|
| 557 |
alpha(2)-Macroglobulin: a novel cytochemical marker characterizing preneoplastic and neoplastic rat liver lesions negative for hitherto established cytochemical markers.Am J Pathol. 2004 Nov;165(5):1479-88. doi: 10.1016/s0002-9440(10)63406-2.
|
| 558 |
The biphasic change of cytosolic acetyl-CoA hydrolase in rat liver during 3'-methyl-4-dimethylaminoazobenzene hepatocarcinogenesis.Jpn J Cancer Res. 1989 Feb;80(2):132-5. doi: 10.1111/j.1349-7006.1989.tb02280.x.
|
| 559 |
Associations between polymorphisms of the ACYP2 gene and Liver cancer risk: A case-control study and meta-analysis.Mol Genet Genomic Med. 2019 Jul;7(7):e00716. doi: 10.1002/mgg3.716. Epub 2019 May 23.
|
| 560 |
ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling.Hepatology. 2003 May;37(5):1056-66. doi: 10.1053/jhep.2003.50205.
|
| 561 |
ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers.PLoS One. 2013 Dec 27;8(12):e81922. doi: 10.1371/journal.pone.0081922. eCollection 2013.
|
| 562 |
Molecular cloning and expression of rat aldolase C messenger RNA during development and hepatocarcinogenesis.Eur J Biochem. 1987 Mar 16;163(3):513-8. doi: 10.1111/j.1432-1033.1987.tb10898.x.
|
| 563 |
Epigenetic silencing of ALX4 regulates microcystin-LR induced hepatocellular carcinoma through the P53 pathway.Sci Total Environ. 2019 Sep 15;683:317-330. doi: 10.1016/j.scitotenv.2019.05.144. Epub 2019 May 15.
|
| 564 |
Angiomotin-like 2 interacts with and negatively regulates AKT.Oncogene. 2017 Aug 10;36(32):4662-4669. doi: 10.1038/onc.2017.101. Epub 2017 Apr 3.
|
| 565 |
Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells.Stem Cells. 2015 Feb;33(2):354-66. doi: 10.1002/stem.1850.
|
| 566 |
LncAPC drives Wnt/-catenin activation and liver TIC self-renewal through EZH2 mediated APC transcriptional inhibition.Mol Carcinog. 2018 Mar;57(3):408-418. doi: 10.1002/mc.22764. Epub 2017 Dec 15.
|
| 567 |
A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage.Nat Commun. 2014 Oct 9;5:5129. doi: 10.1038/ncomms6129.
|
| 568 |
Aquaporins 1, 3 and 5 in Different Tumors, their Expression, Prognosis Value and Role as New Therapeutic Targets.Pathol Oncol Res. 2020 Apr;26(2):615-625. doi: 10.1007/s12253-019-00646-9. Epub 2019 Mar 29.
|
| 569 |
Regulation of white and brown adipocyte differentiation by RhoGAP DLC1.PLoS One. 2017 Mar 30;12(3):e0174761. doi: 10.1371/journal.pone.0174761. eCollection 2017.
|
| 570 |
Ginsenoside Rg3 inhibits the migration and invasion of liver cancer cells by increasing the protein expression of ARHGAP9.Oncol Lett. 2019 Jan;17(1):965-973. doi: 10.3892/ol.2018.9701. Epub 2018 Nov 15.
|
| 571 |
Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma.Int J Cancer. 2013 May 1;132(9):2217-21. doi: 10.1002/ijc.27900. Epub 2012 Nov 20.
|
| 572 |
Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth.Mol Cancer Ther. 2019 Mar;18(3):602-612. doi: 10.1158/1535-7163.MCT-18-0824. Epub 2019 Jan 15.
|
| 573 |
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.Nat Genet. 2016 May;48(5):500-9. doi: 10.1038/ng.3547. Epub 2016 Apr 11.
|
| 574 |
Hepatitis B virus-regulated growth of liver cancer cells occurs through the microRNA-340-5p-activating transcription factor 7-heat shock protein A member 1B axis.Cancer Sci. 2019 May;110(5):1633-1643. doi: 10.1111/cas.14004. Epub 2019 Apr 11.
|
| 575 |
AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of -catenin activation.J Hepatol. 2018 Jun;68(6):1203-1213. doi: 10.1016/j.jhep.2017.12.018. Epub 2018 Mar 7.
|
| 576 |
miR-221-3p and miR-15b-5p promote cell proliferation and invasion by targeting Axin2 in liver cancer.Oncol Lett. 2019 Dec;18(6):6491-6500. doi: 10.3892/ol.2019.11056. Epub 2019 Nov 5.
|
| 577 |
High Expression B3GAT3 Is Related with Poor Prognosis of Liver Cancer.Open Med (Wars). 2019 Feb 26;14:251-258. doi: 10.1515/med-2019-0020. eCollection 2019.
|
| 578 |
The BRUCE-ATR Signaling Axis Is Required for Accurate DNA Replication and Suppression of Liver Cancer Development.Hepatology. 2019 Jun;69(6):2608-2622. doi: 10.1002/hep.30529. Epub 2019 Mar 13.
|
| 579 |
Silencing of the HCCR2 gene induces apoptosis and suppresses the aggressive phenotype of hepatocellular carcinoma cells in culture.J Gastrointest Surg. 2011 Oct;15(10):1807-13. doi: 10.1007/s11605-011-1633-4. Epub 2011 Jul 28.
|
| 580 |
Silencing of Btbd7 Inhibited Epithelial-Mesenchymal Transition and Chemoresistance in CD133(+) Lung Carcinoma A549 Cells.Oncol Res. 2017 May 24;25(5):819-829. doi: 10.3727/096504016X14772349843854. Epub 2016 Oct 26.
|
| 581 |
Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.J Exp Clin Cancer Res. 2019 Jun 6;38(1):237. doi: 10.1186/s13046-019-1239-3.
|
| 582 |
Sorafenib-loaded hydroxyethyl starch-TG100-115 micelles for the treatment of liver cancer based on synergistic treatment.Drug Deliv. 2019 Dec;26(1):756-764. doi: 10.1080/10717544.2019.1642418.
|
| 583 |
Calpain-3 gene expression is decreased during experimental cancer cachexia.Biochim Biophys Acta. 2000 Jun 1;1475(1):5-9. doi: 10.1016/s0304-4165(00)00050-7.
|
| 584 |
Expression Quantitative Trait Loci for CARD8 Contributes to Risk of Two Infection-Related Cancers--Hepatocellular Carcinoma and Cervical Cancer.PLoS One. 2015 Jul 6;10(7):e0132352. doi: 10.1371/journal.pone.0132352. eCollection 2015.
|
| 585 |
Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182.Oncol Rep. 2016 Apr;35(4):2461-5. doi: 10.3892/or.2016.4605. Epub 2016 Feb 1.
|
| 586 |
Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDR.Oncotarget. 2016 Oct 11;7(41):66525-66539. doi: 10.18632/oncotarget.9089.
|
| 587 |
Hypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer.Oncotarget. 2016 Nov 15;7(46):75763-75773. doi: 10.18632/oncotarget.12409.
|
| 588 |
Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of -catenin/TCF/LEF signalling.Cell Prolif. 2019 May;52(3):e12583. doi: 10.1111/cpr.12583. Epub 2019 Feb 22.
|
| 589 |
CD151 supports VCAM-1-mediated lymphocyte adhesion to liver endothelium and is upregulated in chronic liver disease and hepatocellular carcinoma.Am J Physiol Gastrointest Liver Physiol. 2017 Aug 1;313(2):G138-G149. doi: 10.1152/ajpgi.00411.2016. Epub 2017 May 4.
|
| 590 |
KAI1 gene suppresses invasion and metastasis of hepatocellular carcinoma MHCC97-H cells in vitro and in animal models.Liver Int. 2008 Jan;28(1):132-9. doi: 10.1111/j.1478-3231.2007.01620.x. Epub 2007 Nov 19.
|
| 591 |
CDCA5, Transcribed by E2F1, Promotes Oncogenesis by Enhancing Cell Proliferation and Inhibiting Apoptosis via the AKT Pathway in Hepatocellular Carcinoma.J Cancer. 2019 Apr 21;10(8):1846-1854. doi: 10.7150/jca.28809. eCollection 2019.
|
| 592 |
Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma.Hepatology. 2009 Nov;50(5):1453-63. doi: 10.1002/hep.23143.
|
| 593 |
Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation.Carcinogenesis. 2002 Jul;23(7):1139-48. doi: 10.1093/carcin/23.7.1139.
|
| 594 |
RNA Binding Protein CUGBP1 Inhibits Liver Cancer in a Phosphorylation-Dependent Manner.Mol Cell Biol. 2017 Jul 28;37(16):e00128-17. doi: 10.1128/MCB.00128-17. Print 2017 Aug 15.
|
| 595 |
Clinical significance of chromodomain helicase/ATPase DNA binding protein 1-like and human mutL homolog 1 gene expression in cholangiocarcinoma.Oncol Lett. 2018 Sep;16(3):2989-2994. doi: 10.3892/ol.2018.9043. Epub 2018 Jun 28.
|
| 596 |
Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.J Hepatol. 2015 Nov;63(5):1164-72. doi: 10.1016/j.jhep.2015.06.009. Epub 2015 Jun 18.
|
| 597 |
The study on expression of CIAPIN1 interfering hepatocellular carcinoma cell proliferation and its mechanisms.Eur Rev Med Pharmacol Sci. 2017 Jul;21(13):3054-3060.
|
| 598 |
Cold-inducible RNA-binding protein promotes the development of liver cancer.Cancer Sci. 2015 Apr;106(4):352-8. doi: 10.1111/cas.12611. Epub 2015 Mar 3.
|
| 599 |
A Synthetic Dosage Lethal Genetic Interaction Between CKS1B and PLK1 Is Conserved in Yeast and Human Cancer Cells.Genetics. 2016 Oct;204(2):807-819. doi: 10.1534/genetics.116.190231. Epub 2016 Aug 24.
|
| 600 |
Tumor cells of non-hematopoietic and hematopoietic origins express activation-induced C-type lectin, the ligand for killer cell lectin-like receptor F1.Int Immunol. 2010 Sep;22(9):783-90. doi: 10.1093/intimm/dxq430. Epub 2010 Jul 26.
|
| 601 |
RNAs containing mitochondrial ND6 and COI sequences present an abnormal structure in chemically induced rat hepatomas.Nucleic Acids Res. 1989 Jul 11;17(13):5191-206. doi: 10.1093/nar/17.13.5191.
|
| 602 |
In vivo imaging of leucine aminopeptidase activity in drug-induced liver injury and liver cancer via a near-infrared fluorescent probe.Chem Sci. 2017 May 1;8(5):3479-3483. doi: 10.1039/c6sc05712h. Epub 2017 Mar 2.
|
| 603 |
CPSF7 regulates liver cancer growth and metastasis by facilitating WWP2-FL and targeting the WWP2/PTEN/AKT signaling pathway.Biochim Biophys Acta Mol Cell Res. 2020 Feb;1867(2):118624. doi: 10.1016/j.bbamcr.2019.118624. Epub 2019 Dec 12.
|
| 604 |
Investigation of the role of cullin 4A overexpression in human liver cancer.Mol Med Rep. 2018 Sep;18(3):2531-2540. doi: 10.3892/mmr.2018.9233. Epub 2018 Jun 29.
|
| 605 |
Cytoglobin ameliorates the stemness of hepatocellular carcinoma via coupling oxidative-nitrosative stress signals.Mol Carcinog. 2019 Mar;58(3):334-343. doi: 10.1002/mc.22931. Epub 2018 Dec 4.
|
| 606 |
Cloning and characterization of F-LANa, upregulated in human liver cancer.Biochem Biophys Res Commun. 2001 Aug 17;286(2):394-400. doi: 10.1006/bbrc.2001.5390.
|
| 607 |
Clinical significance of aberrant DEUP1 promoter methylation in hepatocellular carcinoma.Oncol Lett. 2019 Aug;18(2):1356-1364. doi: 10.3892/ol.2019.10421. Epub 2019 May 30.
|
| 608 |
DUOX1 Silencing in Mammary Cell Alters the Response to Genotoxic Stress.Oxid Med Cell Longev. 2018 Apr 19;2018:3570526. doi: 10.1155/2018/3570526. eCollection 2018.
|
| 609 |
DUSP16 ablation arrests the cell cycle and induces cellular senescence.FEBS J. 2015 Dec;282(23):4580-94. doi: 10.1111/febs.13518. Epub 2015 Oct 19.
|
| 610 |
The translation initiation factor eIF3i up-regulates vascular endothelial growth factor A, accelerates cell proliferation, and promotes angiogenesis in embryonic development and tumorigenesis.J Biol Chem. 2014 Oct 10;289(41):28310-23. doi: 10.1074/jbc.M114.571356. Epub 2014 Aug 21.
|
| 611 |
Comprehensive study of tumour single nucleotide polymorphism array data reveals significant driver aberrations and disrupted signalling pathways in human hepatocellular cancer.IET Syst Biol. 2014 Apr;8(2):24-32. doi: 10.1049/iet-syb.2013.0027.
|
| 612 |
AGXT2L1 is down-regulated in heptocellular carcinoma and associated with abnormal lipogenesis.J Clin Pathol. 2016 Mar;69(3):215-20. doi: 10.1136/jclinpath-2015-203042. Epub 2015 Aug 20.
|
| 613 |
Identification of factors interacting with hMSH2 in the fetal liver utilizing the yeast two-hybrid system. In vivo interaction through the C-terminal domains of hEXO1 and hMSH2 and comparative expression analysis.Mutat Res. 2000 Jun 30;460(1):41-52. doi: 10.1016/s0921-8777(00)00012-4.
|
| 614 |
Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability.Hum Mol Genet. 2001 Aug 15;10(17):1741-52. doi: 10.1093/hmg/10.17.1741.
|
| 615 |
FAM83H is involved in the progression of hepatocellular carcinoma and is regulated by MYC.Sci Rep. 2017 Jun 12;7(1):3274. doi: 10.1038/s41598-017-03639-3.
|
| 616 |
ProstaglandinE2 promotes liver cancer cell growth by the upregulation of FUSE-binding protein 1 expression.Int J Oncol. 2013 Mar;42(3):1093-104. doi: 10.3892/ijo.2013.1782. Epub 2013 Jan 18.
|
| 617 |
Downregulation and antiproliferative role of FHL3 in breast cancer.IUBMB Life. 2011 Sep;63(9):764-71. doi: 10.1002/iub.502.
|
| 618 |
Opposing Roles of the Forkhead Box Factors FoxM1 and FoxA2 in Liver Cancer.Mol Cancer Res. 2019 May;17(5):1063-1074. doi: 10.1158/1541-7786.MCR-18-0968. Epub 2019 Feb 27.
|
| 619 |
Curcumin Induces p53-Null Hepatoma Cell Line Hep3B Apoptosis through the AKT-PTEN-FOXO4 Pathway.Evid Based Complement Alternat Med. 2017;2017:4063865. doi: 10.1155/2017/4063865. Epub 2017 Jul 9.
|
| 620 |
miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9.Onco Targets Ther. 2019 Mar 22;12:2149-2157. doi: 10.2147/OTT.S197326. eCollection 2019.
|
| 621 |
FUN14 Domain-Containing 1-Mediated Mitophagy Suppresses Hepatocarcinogenesis by Inhibition of Inflammasome Activation in Mice.Hepatology. 2019 Feb;69(2):604-621. doi: 10.1002/hep.30191. Epub 2019 Jan 7.
|
| 622 |
Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells.J Hepatol. 2011 Jan;54(1):122-31. doi: 10.1016/j.jhep.2010.06.026. Epub 2010 Aug 26.
|
| 623 |
Gel-based proteomics of liver cancer progression in rat.Biochim Biophys Acta. 2011 Oct;1814(10):1367-76. doi: 10.1016/j.bbapap.2011.05.018. Epub 2011 Jun 6.
|
| 624 |
Two variants of the human hepatocellular carcinoma-associated HCAP1 gene and their effect on the growth of the human liver cancer cell line Hep3B.Genes Chromosomes Cancer. 2004 Jan;39(1):48-58. doi: 10.1002/gcc.10293.
|
| 625 |
GGPPS1 predicts the biological character of hepatocellular carcinoma in patients with cirrhosis.BMC Cancer. 2014 Apr 9;14:248. doi: 10.1186/1471-2407-14-248.
|
| 626 |
Ultrasensitive detection of glutathione based on liquid crystals in the presence of -glutamyl transpeptidase.Anal Chim Acta. 2018 Dec 21;1040:187-195. doi: 10.1016/j.aca.2018.08.029. Epub 2018 Aug 15.
|
| 627 |
Gene Expression and DNA Methylation Alterations in the Glycine N-Methyltransferase Gene in Diet-Induced Nonalcoholic Fatty Liver Disease-Associated Carcinogenesis.Toxicol Sci. 2019 Aug 1;170(2):273-282. doi: 10.1093/toxsci/kfz110.
|
| 628 |
Golgi protein 73 and its diagnostic value in liver diseases.Cell Prolif. 2019 Mar;52(2):e12538. doi: 10.1111/cpr.12538. Epub 2018 Oct 19.
|
| 629 |
Glypicans as Cancer Therapeutic Targets.Trends Cancer. 2018 Nov;4(11):741-754. doi: 10.1016/j.trecan.2018.09.004. Epub 2018 Sep 28.
|
| 630 |
Changes in S-adenosylmethionine synthetase in human liver cancer: molecular characterization and significance.Hepatology. 1996 Nov;24(5):1090-7. doi: 10.1002/hep.510240519.
|
| 631 |
Demethylation of the HACE1 gene promoter inhibits the proliferation of human liver cancer cells.Oncol Lett. 2019 May;17(5):4361-4368. doi: 10.3892/ol.2019.10139. Epub 2019 Mar 12.
|
| 632 |
Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17.Carcinogenesis. 2009 May;30(5):879-85. doi: 10.1093/carcin/bgp054. Epub 2009 Mar 2.
|
| 633 |
Regression of Fibrosis Stage With Treatment Reduces Long-Term Risk of Liver Cancer in Patients With Hemochromatosis Caused by Mutation in HFE.Clin Gastroenterol Hepatol. 2020 Jul;18(8):1851-1857. doi: 10.1016/j.cgh.2019.10.010. Epub 2019 Oct 14.
|
| 634 |
Phase angle as a severity indicator for liver diseases.Nutrition. 2020 Feb;70:110607. doi: 10.1016/j.nut.2019.110607. Epub 2019 Oct 11.
|
| 635 |
The human HIP gene, overexpressed in primary liver cancer encodes for a C-type carbohydrate binding protein with lactose binding activity.FEBS Lett. 1994 Jan 3;337(1):114-8. doi: 10.1016/0014-5793(94)80640-3.
|
| 636 |
TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients.BMC Cancer. 2012 Mar 8;12:85. doi: 10.1186/1471-2407-12-85.
|
| 637 |
Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.Hepatology. 2012 Jul;56(1):165-75. doi: 10.1002/hep.25643. Epub 2012 Jun 5.
|
| 638 |
Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer.Cancer Lett. 2017 Jun 28;396:53-65. doi: 10.1016/j.canlet.2017.03.013. Epub 2017 Mar 14.
|
| 639 |
Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.Oncotarget. 2017 May 16;8(20):33683-33693. doi: 10.18632/oncotarget.16898.
|
| 640 |
ILF2 Directly Binds and Stabilizes CREB to Stimulate Malignant Phenotypes of Liver Cancer Cells.Anal Cell Pathol (Amst). 2019 Feb 10;2019:1575031. doi: 10.1155/2019/1575031. eCollection 2019.
|
| 641 |
IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma.BMC Gastroenterol. 2010 Oct 26;10:125. doi: 10.1186/1471-230X-10-125.
|
| 642 |
Transcript profiling identifies iqgap2(-/-) mouse as a model for advanced human hepatocellular carcinoma.PLoS One. 2013 Aug 12;8(8):e71826. doi: 10.1371/journal.pone.0071826. eCollection 2013.
|
| 643 |
Integrin alpha 7 correlates with poor clinical outcomes, and it regulates cell proliferation, apoptosis and stemness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma.Cell Signal. 2020 Feb;66:109465. doi: 10.1016/j.cellsig.2019.109465. Epub 2019 Nov 5.
|
| 644 |
A simple robust method of synthesis of copper-silver core-shell nano-particle: evaluation of its structural and chemical properties with anticancer potency.Nanotechnology. 2018 Aug 10;29(32):325102. doi: 10.1088/1361-6528/aac372. Epub 2018 May 9.
|
| 645 |
Expression of junB is markedly stimulated by glycyrrhizin in a human hepatoma cell line.Oncol Rep. 2011 Mar;25(3):609-17. doi: 10.3892/or.2011.1137. Epub 2011 Jan 10.
|
| 646 |
TIP60-dependent acetylation of the SPZ1-TWIST complex promotes epithelial-mesenchymal transition and metastasis in liver cancer.Oncogene. 2019 Jan;38(4):518-532. doi: 10.1038/s41388-018-0457-z. Epub 2018 Aug 28.
|
| 647 |
KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma.Aging (Albany NY). 2019 Oct 2;11(19):8169-8182. doi: 10.18632/aging.102311. Epub 2019 Oct 2.
|
| 648 |
KLF11 promotes gastric cancer invasion and migration by increasing Twist1 expression.Neoplasma. 2019 Jan 15;66(1):92-100. doi: 10.4149/neo_2018_180325N201. Epub 2018 Sep 4.
|
| 649 |
Screening and identification of the tumor-associated antigen CK10, a novel potential liver cancer marker.FEBS Open Bio. 2017 Mar 21;7(5):627-635. doi: 10.1002/2211-5463.12122. eCollection 2017 May.
|
| 650 |
Cytokeratin 8/18 as a new marker of mouse liver preneoplastic lesions.Toxicol Appl Pharmacol. 2010 Jan 1;242(1):47-55. doi: 10.1016/j.taap.2009.09.013. Epub 2009 Sep 29.
|
| 651 |
Low density lipoprotein receptor class A domain containing 4 (LDLRAD4) promotes tumorigenesis of hepatic cancer cells.Exp Cell Res. 2017 Nov 15;360(2):189-198. doi: 10.1016/j.yexcr.2017.09.005. Epub 2017 Sep 6.
|
| 652 |
Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development.Liver Int. 2017 Jun;37(6):879-887. doi: 10.1111/liv.13341. Epub 2016 Dec 28.
|
| 653 |
Dynamics and predicted drug response of a gene network linking dedifferentiation with beta-catenin dysfunction in hepatocellular carcinoma.J Hepatol. 2019 Aug;71(2):323-332. doi: 10.1016/j.jhep.2019.03.024. Epub 2019 Apr 4.
|
| 654 |
Derepression of LOXL4 inhibits liver cancer growth by reactivating compromised p53.Cell Death Differ. 2019 Nov;26(11):2237-2252. doi: 10.1038/s41418-019-0293-x. Epub 2019 Feb 6.
|
| 655 |
Nuclear receptor CAR-regulated expression of the FAM84A gene during the development of mouse liver tumors.Int J Oncol. 2011 Jun;38(6):1511-20. doi: 10.3892/ijo.2011.980. Epub 2011 Mar 17.
|
| 656 |
SPAG9/MKK3/p38 axis is a novel therapeutic target for liver cancer.Oncol Rep. 2019 Apr;41(4):2329-2336. doi: 10.3892/or.2019.6987. Epub 2019 Jan 30.
|
| 657 |
Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/-catenin Signaling Pathway.Molecules. 2019 Jan 22;24(3):393. doi: 10.3390/molecules24030393.
|
| 658 |
MARVELD1 attenuates arsenic trioxide-induced apoptosis in liver cancer cells by inhibiting reactive oxygen species production. Ann Transl Med. 2019 May;7(9):200. doi: 10.21037/atm.2019.04.38.
|
| 659 |
Minichromosome maintenance helicase paralog MCM9 is dispensible for DNA replication but functions in germ-line stem cells and tumor suppression.Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17702-7. doi: 10.1073/pnas.1113524108. Epub 2011 Oct 10.
|
| 660 |
Absent expression of miR-30a promotes the growth of lung cancer cells by targeting MEF2D.Oncol Lett. 2018 Jul;16(1):1173-1179. doi: 10.3892/ol.2018.8719. Epub 2018 May 16.
|
| 661 |
RNA m(6)A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail.Nat Commun. 2019 May 6;10(1):2065. doi: 10.1038/s41467-019-09865-9.
|
| 662 |
LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib-mediated death via inhibiting the AMPK-Mfn2 signaling pathway.Cancer Cell Int. 2019 Mar 18;19:60. doi: 10.1186/s12935-019-0778-1. eCollection 2019.
|
| 663 |
Specific delivery of microRNA93 into HBV-replicating hepatocytes downregulates protein expression of liver cancer susceptible gene MICA.Oncotarget. 2014 Jul 30;5(14):5581-90. doi: 10.18632/oncotarget.2143.
|
| 664 |
Genetic ablation of TAZ induces HepG2 liver cancer cell apoptosis through activating the CaMKII/MIEF1 signaling pathway.Onco Targets Ther. 2019 Mar 1;12:1765-1779. doi: 10.2147/OTT.S196142. eCollection 2019.
|
| 665 |
Sirtuin-1/Mitochondrial Ribosomal Protein S5 Axis Enhances the Metabolic Flexibility of Liver Cancer Stem Cells.Hepatology. 2019 Oct;70(4):1197-1213. doi: 10.1002/hep.30622. Epub 2019 Jun 26.
|
| 666 |
Metallothionein 1 h tumour suppressor activity in prostate cancer is mediated by euchromatin methyltransferase 1.J Pathol. 2013 Jun;230(2):184-93. doi: 10.1002/path.4169.
|
| 667 |
In vitro synthesis of the trifunctional protein, methylenetetrahydrofolate dehydrogenase--methenyltetrahydrofolate cyclohydrolase--formyltetrahydrofolate synthetase, in normal and transformed cells.Can J Biochem Cell Biol. 1985 Nov;63(11):1189-93.
|
| 668 |
Non-SMC Condensin I Complex, Subunit G (NCAPG) is a Novel Mitotic Gene Required for Hepatocellular Cancer Cell Proliferation and Migration.Oncol Res. 2018 Mar 5;26(2):269-276. doi: 10.3727/096504017X15075967560980. Epub 2017 Oct 18.
|
| 669 |
Increased level of the mitochondrial ND5 transcript in chemically induced rat hepatomas.Exp Cell Res. 1989 Sep;184(1):158-66. doi: 10.1016/0014-4827(89)90374-1.
|
| 670 |
Inhibition of Hec1 as a novel approach for treatment of primary liver cancer.Cancer Chemother Pharmacol. 2014 Sep;74(3):511-20. doi: 10.1007/s00280-014-2540-7. Epub 2014 Jul 20.
|
| 671 |
The prognostic value of decreased NDRG1 expression in patients with digestive system cancers: A meta-analysis.Medicine (Baltimore). 2018 Oct;97(41):e12455. doi: 10.1097/MD.0000000000012455.
|
| 672 |
Loss of NDRG2 in liver microenvironment inhibits cancer liver metastasis by regulating tumor associate macrophages polarization.Cell Death Dis. 2018 Feb 14;9(2):248. doi: 10.1038/s41419-018-0284-8.
|
| 673 |
Niemann-Pick type C2 protein regulates liver cancer progression via modulating ERK1/2 pathway: Clinicopathological correlations and therapeutical implications.Int J Cancer. 2015 Sep 15;137(6):1341-51. doi: 10.1002/ijc.29507. Epub 2015 Mar 24.
|
| 674 |
The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis.Genes Chromosomes Cancer. 2013 Feb;52(2):126-39. doi: 10.1002/gcc.22012. Epub 2012 Sep 25.
|
| 675 |
Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19-FGF4-KLB Pathway Inhibition.Cancer Discov. 2019 Dec;9(12):1646-1649. doi: 10.1158/2159-8290.CD-19-1156.
|
| 676 |
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance.Cell Death Dis. 2016 Jun 23;7(6):e2269. doi: 10.1038/cddis.2016.175.
|
| 677 |
Downregulation of nucleolar and spindle-associated protein 1 expression suppresses liver cancer cell function.Exp Ther Med. 2019 Apr;17(4):2969-2978. doi: 10.3892/etm.2019.7314. Epub 2019 Feb 26.
|
| 678 |
Inhibiting the Hexosamine Biosynthetic Pathway Lowers O-GlcNAcylation Levels and Sensitizes Cancer to Environmental Stress.Biochemistry. 2020 Sep 1;59(34):3169-3179. doi: 10.1021/acs.biochem.9b00560. Epub 2019 Nov 18.
|
| 679 |
Investigating the expression, effect and tumorigenic pathway of PADI2 in tumors.Onco Targets Ther. 2017 Mar 8;10:1475-1485. doi: 10.2147/OTT.S92389. eCollection 2017.
|
| 680 |
Cancers Due to Excess Weight, Low Physical Activity, and Unhealthy Diet.Dtsch Arztebl Int. 2018 Sep 3;115(35-36):578-585. doi: 10.3238/arztebl.2018.0578.
|
| 681 |
Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122.Oncotarget. 2015 Dec 1;6(38):40822-35. doi: 10.18632/oncotarget.5812.
|
| 682 |
Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression.J Exp Clin Cancer Res. 2019 Feb 20;38(1):92. doi: 10.1186/s13046-019-1106-2.
|
| 683 |
PES1 In Liver Cancer: A Prognostic Biomarker With Tumorigenic Roles.Cancer Manag Res. 2019 Nov 14;11:9641-9653. doi: 10.2147/CMAR.S226471. eCollection 2019.
|
| 684 |
Metformin attenuates hepatoma cell proliferation by decreasing glycolytic flux through the HIF-1/PFKFB3/PFK1 pathway.Life Sci. 2019 Dec 15;239:116966. doi: 10.1016/j.lfs.2019.116966. Epub 2019 Oct 15.
|
| 685 |
A novel human homologue of Drosophila polycomblike gene is up-regulated in multiple cancers.Gene. 2004 Dec 8;343(1):69-78. doi: 10.1016/j.gene.2004.09.006.
|
| 686 |
Polymorphisms in POLG were associated with the prognosis and mtDNA content in hepatocellular carcinoma patients.Bull Cancer. 2017 Jun;104(6):500-507. doi: 10.1016/j.bulcan.2017.02.005. Epub 2017 Apr 28.
|
| 687 |
The POLR2E rs3787016 polymorphism is strongly associated with the risk of female breast and cervical cancer.Pathol Res Pract. 2019 May;215(5):1061-1065. doi: 10.1016/j.prp.2019.02.015. Epub 2019 Feb 27.
|
| 688 |
Cyclophilin J is a novel peptidyl-prolyl isomerase and target for repressing the growth of hepatocellular carcinoma.PLoS One. 2015 May 28;10(5):e0127668. doi: 10.1371/journal.pone.0127668. eCollection 2015.
|
| 689 |
Mitochondrial prohibitins and septin 9 are implicated in the onset of rat hepatocarcinogenesis.Toxicol Sci. 2011 Jan;119(1):61-72. doi: 10.1093/toxsci/kfq307. Epub 2010 Oct 8.
|
| 690 |
Protein phosphatase 2 regulatory subunit B''Alpha silencing inhibits tumor cell proliferation in liver cancer.Cancer Med. 2019 Dec;8(18):7741-7753. doi: 10.1002/cam4.2620. Epub 2019 Oct 24.
|
| 691 |
Dependence of artesunate on long noncoding RNA-RP11 to inhibit epithelial-mesenchymal transition of hepatocellular carcinoma.J Cell Biochem. 2019 Apr;120(4):6026-6034. doi: 10.1002/jcb.27889. Epub 2018 Oct 18.
|
| 692 |
Expression of liver cancer associated gene HCCA3.World J Gastroenterol. 2001 Dec;7(6):821-5. doi: 10.3748/wjg.v7.i6.821.
|
| 693 |
Survival and inflammation promotion effect of PTPRO in fulminant hepatitis is associated with NF-B activation.J Immunol. 2014 Nov 15;193(10):5161-70. doi: 10.4049/jimmunol.1303354. Epub 2014 Oct 22.
|
| 694 |
PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer.J Transl Med. 2019 Oct 16;17(1):343. doi: 10.1186/s12967-019-2091-0.
|
| 695 |
Pygopus-2 promotes invasion and metastasis of hepatic carcinoma cell by decreasing E-cadherin expression.Oncotarget. 2015 May 10;6(13):11074-86. doi: 10.18632/oncotarget.3570.
|
| 696 |
Long non-coding RNA TUC338 is functionally involved in sorafenib-sensitized hepatocarcinoma cells by targeting RASAL1.Oncol Rep. 2017 Jan;37(1):273-280. doi: 10.3892/or.2016.5248. Epub 2016 Nov 15.
|
| 697 |
Changes in Radixin Expression and Interaction with Efflux Transporters in the Liver of Adjuvant-Induced Arthritic Rats.Inflammation. 2020 Feb;43(1):85-94. doi: 10.1007/s10753-019-01097-9.
|
| 698 |
RecQL1 DNA repair helicase: A potential tumor marker and therapeutic target against hepatocellular carcinoma.Int J Mol Med. 2010 Apr;25(4):537-45. doi: 10.3892/ijmm_00000375.
|
| 699 |
The RFC1 80G>A, among Common One-Carbon Polymorphisms, Relates to Survival Rate According to DNA Global Methylation in Primary Liver Cancers.PLoS One. 2016 Dec 9;11(12):e0167534. doi: 10.1371/journal.pone.0167534. eCollection 2016.
|
| 700 |
Prolonged survival of patients with colorectal cancer is associated with a higher regucalcin gene expression: Overexpression of regucalcin suppresses the growth of human colorectal carcinoma cells invitro.Int J Oncol. 2018 Sep;53(3):1313-1322. doi: 10.3892/ijo.2018.4458. Epub 2018 Jun 28.
|
| 701 |
Over-expression of regulator of G protein signaling 5 promotes tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma cells.J Surg Oncol. 2013 Sep;108(3):192-6. doi: 10.1002/jso.23367. Epub 2013 Jul 19.
|
| 702 |
8-bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of Twist signaling.Int J Oncol. 2013 Nov;43(5):1719-29. doi: 10.3892/ijo.2013.2071. Epub 2013 Aug 21.
|
| 703 |
Dysfunction of IKZF1/MYC/MDIG axis contributes to liver cancer progression through regulating H3K9me3/p21 activity.Cell Death Dis. 2017 May 4;8(5):e2766. doi: 10.1038/cddis.2017.165.
|
| 704 |
Tudor domain-containing protein 4 as a potential cancer/testis antigen in liver cancer.Tohoku J Exp Med. 2011 May;224(1):41-6. doi: 10.1620/tjem.224.41.
|
| 705 |
Prognostic value of increased expression of RACO-1 in patients with hepatitis B-related hepatocellular carcinoma.Ther Clin Risk Manag. 2017 Feb 15;13:191-200. doi: 10.2147/TCRM.S125331. eCollection 2017.
|
| 706 |
Synthesis, Docking Studies into CDK-2 and Anticancer Activity of New Derivatives Based Pyrimidine Scaffold and Their Derived Glycosides.Mini Rev Med Chem. 2019;19(13):1093-1110. doi: 10.2174/1389557519666190312165717.
|
| 707 |
MicroRNA-300 inhibits the growth of hepatocellular carcinoma cells by downregulating CREPT/Wnt/-catenin signaling.Oncol Lett. 2019 Oct;18(4):3743-3753. doi: 10.3892/ol.2019.10712. Epub 2019 Aug 5.
|
| 708 |
Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression.Int J Cancer. 2020 Jun 15;146(12):3410-3422. doi: 10.1002/ijc.32787. Epub 2019 Nov 28.
|
| 709 |
New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation.Gastroenterology. 2019 Dec;157(6):1615-1629.e17. doi: 10.1053/j.gastro.2019.08.022. Epub 2019 Aug 22.
|
| 710 |
Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma.J Hepatol. 2006 Dec;45(6):825-35. doi: 10.1016/j.jhep.2006.06.016. Epub 2006 Jul 28.
|
| 711 |
Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing.Oncogene. 2014 Sep 25;33(39):4786-94. doi: 10.1038/onc.2013.424. Epub 2013 Oct 21.
|
| 712 |
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.BMC Cancer. 2008 Jul 18;8:200. doi: 10.1186/1471-2407-8-200.
|
| 713 |
Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient Survivals.Prostate. 2017 May;77(7):718-728. doi: 10.1002/pros.23302. Epub 2017 Feb 23.
|
| 714 |
Enhanced expression of adaptor molecule p46 Shc in nuclei of hepatocellular carcinoma cells: study of LEC rats.Int J Oncol. 2004 Oct;25(4):1089-96.
|
| 715 |
SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.J Exp Clin Cancer Res. 2019 Jun 13;38(1):252. doi: 10.1186/s13046-019-1246-4.
|
| 716 |
[Changes in TGF-beta1/Smads signaling pathway in rats with chemical hepatocarcinogenesis].Nan Fang Yi Ke Da Xue Xue Bao. 2008 Oct;28(10):1848-52.
|
| 717 |
Overexpression of the structural maintenance of chromosome 4 protein is associated with tumor de-differentiation, advanced stage and vascular invasion of primary liver cancer.Oncol Rep. 2012 Oct;28(4):1263-8. doi: 10.3892/or.2012.1929. Epub 2012 Jul 24.
|
| 718 |
Downregulation of sorting nexin 10 is associated with overexpression of miR-30d during liver cancer progression in rats.Tumour Biol. 2017 Apr;39(4):1010428317695932. doi: 10.1177/1010428317695932.
|
| 719 |
A novel SOCS5/miR-18/miR-25 axis promotes tumorigenesis in liver cancer.Int J Cancer. 2019 Jan 15;144(2):311-321. doi: 10.1002/ijc.31857. Epub 2018 Nov 9.
|
| 720 |
SPIN1 triggers abnormal lipid metabolism and enhances tumor growth in liver cancer.Cancer Lett. 2020 Feb 1;470:54-63. doi: 10.1016/j.canlet.2019.11.032. Epub 2019 Nov 29.
|
| 721 |
Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways.J Hepatol. 2012 Sep;57(3):577-83. doi: 10.1016/j.jhep.2012.04.026. Epub 2012 May 19.
|
| 722 |
Activation of serum response factor in the liver of Long-Evans Cinnamon (LEC) rat.Cancer Lett. 1997 Nov 11;119(2):137-41. doi: 10.1016/s0304-3835(97)00263-2.
|
| 723 |
Modification of 2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway.Int J Cancer. 2018 Nov 1;143(9):2319-2330. doi: 10.1002/ijc.31737. Epub 2018 Sep 7.
|
| 724 |
The Oncogenic Potential of SUV39H2: A Comprehensive and Perspective View.J Cancer. 2019 Jan 1;10(3):721-729. doi: 10.7150/jca.28254. eCollection 2019.
|
| 725 |
Expression of protein TARBP1 in human hepatocellular carcinoma and its prognostic significance.Int J Clin Exp Pathol. 2015 Aug 1;8(8):9089-96. eCollection 2015.
|
| 726 |
Intracellular localization and sustained prodrug cell killing activity of TAT-HSVTK fusion protein in hepatocelullar carcinoma cells.Mol Cells. 2006 Feb 28;21(1):104-11.
|
| 727 |
MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA.Biochem Biophys Res Commun. 2015 May 8;460(3):793-8. doi: 10.1016/j.bbrc.2015.03.108. Epub 2015 Mar 28.
|
| 728 |
Co-delivery of LETM1 and CTMP synergistically inhibits tumor growth in H-ras12V liver cancer model mice.Cancer Gene Ther. 2013 Mar;20(3):186-94. doi: 10.1038/cgt.2013.6. Epub 2013 Feb 8.
|
| 729 |
Sp1-mediated ectopic expression of T-cell lymphoma invasion and metastasis 2 in hepatocellular carcinoma.Cancer Med. 2016 Mar;5(3):465-77. doi: 10.1002/cam4.611. Epub 2016 Jan 14.
|
| 730 |
TIGD1, a gene of unknown function, involves cell-cycle progression and correlates with poor prognosis in human cancer.J Cell Biochem. 2019 Jun;120(6):9758-9767. doi: 10.1002/jcb.28256. Epub 2018 Dec 11.
|
| 731 |
The positive correlation of TIPRL with LC3 and CD133 contributes to cancer aggressiveness: potential biomarkers for early liver cancer.Sci Rep. 2019 Nov 14;9(1):16802. doi: 10.1038/s41598-019-53191-5.
|
| 732 |
Decreased expression of ZO-1 is associated with tumor metastases in liver cancer.Oncol Lett. 2019 Feb;17(2):1859-1864. doi: 10.3892/ol.2018.9765. Epub 2018 Nov 27.
|
| 733 |
Adenovirus-mediated delivery of siRNA targeting TM4SF4 attenuated liver cancer cell growth in vitro and in vivo.Acta Biochim Biophys Sin (Shanghai). 2013 Mar;45(3):213-9. doi: 10.1093/abbs/gms115. Epub 2013 Jan 7.
|
| 734 |
Abnormal accumulation of human transmembrane (TMEM)-176A and 176B proteins is associated with cancer pathology.Acta Histochem. 2012 Nov;114(7):705-12. doi: 10.1016/j.acthis.2011.12.006. Epub 2012 Jan 12.
|
| 735 |
The Expression of TMEM74 in Liver Cancer and Lung Cancer Correlating With Survival Outcomes.Appl Immunohistochem Mol Morphol. 2019 Sep;27(8):618-625. doi: 10.1097/PAI.0000000000000659.
|
| 736 |
Effects of TMEM9 gene on cell progression in hepatocellular carcinoma by RNA interference.Oncol Rep. 2016 Jul;36(1):299-305. doi: 10.3892/or.2016.4821. Epub 2016 May 19.
|
| 737 |
Tropomodulin3 promotes liver cancer progression by activating the MAPK/ERK signaling pathway.Oncol Rep. 2019 May;41(5):3060-3068. doi: 10.3892/or.2019.7052. Epub 2019 Mar 7.
|
| 738 |
The siRNA silencing of DcR3 expression induces Fas ligand-mediated apoptosis in HepG2 cells.Exp Ther Med. 2018 May;15(5):4370-4378. doi: 10.3892/etm.2018.5964. Epub 2018 Mar 19.
|
| 739 |
The mitochondrial type IB topoisomerase drives mitochondrial translation and carcinogenesis.Nat Commun. 2019 Jan 8;10(1):83. doi: 10.1038/s41467-018-07922-3.
|
| 740 |
miR-149* Suppresses Liver Cancer Progression by Down-Regulating Tumor Necrosis Factor Receptor 1-Associated Death Domain Protein Expression.Am J Pathol. 2020 Feb;190(2):469-483. doi: 10.1016/j.ajpath.2019.10.010. Epub 2019 Nov 26.
|
| 741 |
Construction of Traf3 knockout liver cancer cell line using CRISPR/Cas9 system.J Cell Biochem. 2019 Sep;120(9):14908-14915. doi: 10.1002/jcb.28753. Epub 2019 Apr 23.
|
| 742 |
KIAA1114, a full-length protein encoded by the trophinin gene, is a novel surface marker for isolating tumor-initiating cells of multiple hepatocellular carcinoma subtypes.Oncotarget. 2014 Mar 15;5(5):1226-40. doi: 10.18632/oncotarget.1677.
|
| 743 |
High Trophinin-Associated Protein Expression Is an Independent Predictor of Poor Survival in Liver Cancer.Dig Dis Sci. 2019 Jan;64(1):137-143. doi: 10.1007/s10620-018-5315-x. Epub 2018 Oct 4.
|
| 744 |
Depletion of TRRAP Induces p53-Independent Senescence in Liver Cancer by Down-Regulating Mitotic Genes.Hepatology. 2020 Jan;71(1):275-290. doi: 10.1002/hep.30807. Epub 2019 Aug 11.
|
| 745 |
HBV upregulates AP-1 complex subunit mu-1 expression via the JNK pathway to promote proliferation of liver cancer cells.Oncol Lett. 2019 Jul;18(1):456-464. doi: 10.3892/ol.2019.10291. Epub 2019 Apr 30.
|
| 746 |
HBV triggers APOBEC2 expression through miR?22 regulation and affects the proliferation of liver cancer cells.Int J Oncol. 2019 Nov;55(5):1137-1148. doi: 10.3892/ijo.2019.4870. Epub 2019 Sep 4.
|
| 747 |
Arf6-driven endocytic recycling of CD147 determines HCC malignant phenotypes.J Exp Clin Cancer Res. 2019 Nov 21;38(1):471. doi: 10.1186/s13046-019-1464-9.
|
| 748 |
Familial intrahepatic cholestasis: New and wide perspectives.Dig Liver Dis. 2019 Jul;51(7):922-933. doi: 10.1016/j.dld.2019.04.013. Epub 2019 May 16.
|
| 749 |
LncRNA HAND2-AS1 promotes liver cancer stem cell self-renewal via BMP signaling.EMBO J. 2019 Sep 2;38(17):e101110. doi: 10.15252/embj.2018101110. Epub 2019 Jul 23.
|
| 750 |
CBX3/HP1 promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.Aging (Albany NY). 2019 Aug 2;11(15):5483-5497. doi: 10.18632/aging.102132. Epub 2019 Aug 2.
|
| 751 |
CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma.Mol Med Rep. 2016 Aug;14(2):1509-14. doi: 10.3892/mmr.2016.5410. Epub 2016 Jun 17.
|
| 752 |
Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms.J Exp Clin Cancer Res. 2019 Nov 8;38(1):458. doi: 10.1186/s13046-019-1444-0.
|
| 753 |
Role of miR-182-5p overexpression in trichloroethylene-induced abnormal cell cycle functions in human HepG2 cells.J Toxicol Environ Health A. 2019;82(16):920-927. doi: 10.1080/15287394.2019.1666550. Epub 2019 Sep 15.
|
| 754 |
Claudin-1 silencing increases sensitivity of liver cancer HepG2 cells to 5-fluorouracil by inhibiting autophagy.Oncol Lett. 2019 Dec;18(6):5709-5716. doi: 10.3892/ol.2019.10967. Epub 2019 Oct 8.
|
| 755 |
DIS3L2 Promotes Progression of Hepatocellular Carcinoma via hnRNP U-Mediated Alternative Splicing.Cancer Res. 2019 Oct 1;79(19):4923-4936. doi: 10.1158/0008-5472.CAN-19-0376. Epub 2019 Jul 22.
|
| 756 |
Upregulation of EPS8L3 is associated with tumorigenesis and poor prognosis in patients with liver cancer.Mol Med Rep. 2019 Sep;20(3):2493-2499. doi: 10.3892/mmr.2019.10471. Epub 2019 Jul 4.
|
| 757 |
Expression of Clusterin suppresses Cr(VI)-induced premature senescence through activation of PI3K/AKT pathway.Ecotoxicol Environ Saf. 2019 Nov 15;183:109465. doi: 10.1016/j.ecoenv.2019.109465. Epub 2019 Jul 31.
|
| 758 |
Tg737 acts as a key driver of invasion and migration in liver cancer stem cells and correlates with poor prognosis in patients with hepatocellular carcinoma.Exp Cell Res. 2017 Sep 15;358(2):217-226. doi: 10.1016/j.yexcr.2017.06.021. Epub 2017 Jun 27.
|
| 759 |
CRISPR/Cas9-based editing of a sensitive transcriptional regulatory element to achieve cell type-specific knockdown of the NEMO scaffold protein.PLoS One. 2019 Sep 25;14(9):e0222588. doi: 10.1371/journal.pone.0222588. eCollection 2019.
|
| 760 |
The Tumor Suppressor Interferon Regulatory Factor 2 Binding Protein 2 Regulates Hippo Pathway in Liver Cancer by a Feedback Loop in Mice.Hepatology. 2020 Jun;71(6):1988-2004. doi: 10.1002/hep.30961. Epub 2020 Feb 16.
|
| 761 |
Expression of La Ribonucleoprotein Domain Family Member 4B (LARP4B) in Liver Cancer and Their Clinical and Prognostic Significance.Dis Markers. 2019 Oct 22;2019:1569049. doi: 10.1155/2019/1569049. eCollection 2019.
|
| 762 |
Knockdown MTMR14 promotes cell apoptosis and inhibits migration in liver cancer cells.Gene. 2019 Apr 5;691:106-113. doi: 10.1016/j.gene.2018.11.099. Epub 2018 Dec 23.
|
| 763 |
COUP-TFII is a modulator of cell-type-specific genetic programs based on genomic localization maps.J Biotechnol. 2019 Aug 10;301:11-17. doi: 10.1016/j.jbiotec.2019.05.305. Epub 2019 May 31.
|
| 764 |
Nucleoporin Nup155 is part of the p53 network in liver cancer.Nat Commun. 2019 May 14;10(1):2147. doi: 10.1038/s41467-019-10133-z.
|
| 765 |
OGDHL Expression as a Prognostic Biomarker for Liver Cancer Patients.Dis Markers. 2019 Oct 17;2019:9037131. doi: 10.1155/2019/9037131. eCollection 2019.
|
| 766 |
The deubiquitinating enzyme OTUD1 antagonizes BH3-mimetic inhibitor induced cell death through regulating the stability of the MCL1 protein.Cancer Cell Int. 2019 Aug 27;19:222. doi: 10.1186/s12935-019-0936-5. eCollection 2019.
|
| 767 |
PGM5: a novel diagnostic and prognostic biomarker for liver cancer.PeerJ. 2019 Jun 11;7:e7070. doi: 10.7717/peerj.7070. eCollection 2019.
|
| 768 |
Phosphorylase Kinase Represents a Novel Prognostic Biomarker and Inhibits Malignant Phenotypes of Liver Cancer Cell.Int J Biol Sci. 2019 Sep 7;15(12):2596-2606. doi: 10.7150/ijbs.33278. eCollection 2019.
|
| 769 |
Identification and characterization of sexual dimorphismlinked gene expression profile in hepatocellular carcinoma.Oncol Rep. 2019 Sep;42(3):937-952. doi: 10.3892/or.2019.7217. Epub 2019 Jun 28.
|
| 770 |
Inhibition of PIKfyve using YM201636 suppresses the growth of liver cancer via the induction of autophagy.Oncol Rep. 2019 Mar;41(3):1971-1979. doi: 10.3892/or.2018.6928. Epub 2018 Dec 12.
|
| 771 |
RETRACTED: HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells.EBioMedicine. 2019 Oct;48:117-129. doi: 10.1016/j.ebiom.2019.09.012. Epub 2019 Sep 14.
|
| 772 |
Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA.Drug Des Devel Ther. 2019 Apr 23;13:1289-1300. doi: 10.2147/DDDT.S200610. eCollection 2019.
|
| 773 |
SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer.EBioMedicine. 2019 Feb;40:406-421. doi: 10.1016/j.ebiom.2018.12.031. Epub 2018 Dec 26.
|
| 774 |
Silencing stomatin-like protein 2 attenuates tumor progression and inflammatory response through repressing CD14 in liver cancer.Onco Targets Ther. 2019 Sep 9;12:7361-7373. doi: 10.2147/OTT.S215131. eCollection 2019.
|
| 775 |
[(18)F] Clofarabine for PET Imaging of Hepatocellular Carcinoma.Cancers (Basel). 2019 Nov 7;11(11):1748. doi: 10.3390/cancers11111748.
|
| 776 |
The special stemness functions of Tbx3 in stem cells and cancer development.Semin Cancer Biol. 2019 Aug;57:105-110. doi: 10.1016/j.semcancer.2018.09.010. Epub 2018 Sep 27.
|
| 777 |
Tcf7l1 Acts as a Suppressor for the Self-Renewal of Liver Cancer Stem Cells and Is Regulated by IGF/MEK/ERK Signaling Independent of -Catenin.Stem Cells. 2019 Nov;37(11):1389-1400. doi: 10.1002/stem.3063. Epub 2019 Aug 26.
|
| 778 |
CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.Cell Death Dis. 2019 Sep 9;10(9):644. doi: 10.1038/s41419-019-1894-5.
|
| 779 |
TRIM29 prevents hepatocellular carcinoma progression by inhibiting Wnt/-catenin signaling pathway.Acta Biochim Biophys Sin (Shanghai). 2019 Jan 1;51(1):68-77. doi: 10.1093/abbs/gmy151.
|
|
|
|
|
|
|
